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ABSTRACT 
Analysis of transcriptomes from salivary glands and midgut of the Hessian fly 
[Mayetiola destructor (Say)] identified a diverse set of cDNAs that were categorized into 
five groups, group I – V, based on their phylogenetic relationship. All five of these 
groups may encode putative protease inhibitors based on structural similarity with known 
proteins. The sequences of these putative proteins among different groups are highly 
diversified. However, sequence identity and structural analysis of the proteins revealed 
that all of them contained high cysteine residues that were completely conserved at their 
respective positions among these otherwise diversified proteins. Analysis of bacterial 
artificial chromosome (BAC) DNA for two groups, group I (11A6) and group II (14A4), 
indicated that group I might be a single copy gene or genes with low copy number 
whereas group II exists as multiple copies clustered within the Hessian fly genome. To 
test the inhibitory activity and specificity of these putative proteins, recombinant proteins 
were generated. Enzymatic analysis of the recombinant proteins against commercial and 
insect gut proteases demonstrated that recombinant proteins indeed are strong inhibitors 
of proteases with different specificities. Northern analysis of the representative members 
of five groups revealed that the group I-IV genes were expressed exclusively in the larval 
stage with variations among groups at different larval stages. The group V (11C4) genes 
were expressed in the late larval and pupal stage. Tissue specific gene expression analysis 
revealed that group I-IV genes were predominantly expressed in malpighian tubules 
whereas the group V genes were abundantly expressed in the salivary glands. 
Localization experiments with the antibody for representative members from group II 
(14A4) demonstrated that the protein was predominantly localized in the malpighian 
tubules and in low amounts in the midgut, suggesting that malpighian tubules are the 
primary tissue of 14A4 inhibitor synthesis. The overall results indicated that the Hessian 
fly contains a complex network of genes that code for protease inhibitors which regulate 
protease activities through different developmental stages of the insect. 
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Analysis of transcriptomes from salivary glands and midgut of the Hessian fly [Mayetiola 
destructor (Say)] identified a diverse set of cDNAs that were categorized into five 
groups, group I – V, based on their phylogenetic relationship. All five of these groups 
may encode putative protease inhibitors based on structural similarity with known 
proteins. The sequences of these putative proteins among different groups are highly 
diversified. However, sequence identity and structural analysis of the proteins revealed 
that all of them contained high cysteine residues that were completely conserved at their 
respective positions among these otherwise diversified proteins. Analysis of bacterial 
artificial chromosome (BAC) DNA for two groups, group I (11A6) and group II (14A4), 
indicated that group I might be a single copy gene or genes with low copy number 
whereas group II exists as multiple copies clustered within the Hessian fly genome. To 
test the inhibitory activity and specificity of these putative proteins, recombinant proteins 
were generated. Enzymatic analysis of the recombinant proteins against commercial and 
insect gut proteases demonstrated that recombinant proteins indeed are strong inhibitors 
of proteases with different specificities. Northern analysis of the representative members 
of five groups revealed that the group I-IV genes were expressed exclusively in the larval 
stage with variations among groups at different larval stages. The group V (11C4) genes 
were expressed in the late larval and pupal stage. Tissue specific gene expression analysis 
revealed that group I-IV genes were predominantly expressed in malpighian tubules 
whereas the group V genes were abundantly expressed in the salivary glands. 
Localization experiments with the antibody for representative members from group II 
(14A4) demonstrated that the protein was predominantly localized in the malpighian 
tubules and in low amounts in the midgut, suggesting that malpighian tubules are the 
primary tissue of 14A4 inhibitor synthesis. The overall results indicated that the Hessian 
fly contains a complex network of genes that code for protease inhibitors which regulate 
protease activities through different developmental stages of the insect. 
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1. Review of Literature 
1.1 Proteolysis 
 Proteolysis is the breakdown of proteins into amino acids through the action of 
various proteases. Proteolysis is involved in various cellular and biological processes 
such as DNA replication, cell-cycle progression, cell proliferation, and migration, 
morphogenesis and tissue remodeling, neuronal outgrowth, haemostasis, wound healing, 
immunity, angiogenesis and apoptosis in all living organisms (Sternlicht and Werb, 
2001). There are two forms of proteolysis: limited proteolysis and non-limited proteolysis 
(Thumm, 1993).  Limited proteolysis leads to the activation of immature proteins, 
inactive proteins, or zymogens by cleavage of one or a limited number of peptide bonds. 
Non-limited proteolysis is a process where the active biological molecules are rendered 
inactive through hydrolysis of many peptide bonds in the molecule. The amino acid 
constituents generated through this hydrolysis are recycled back to protein synthesis. 
Alternatively these amino acids can be used for metabolism to produce energy. Limited 
and non-limited proteolysis are the two major tools for a given cell or organism to 
activate, inactivate, or dispose proteins at a given time to control its biological processes.  
1.1.1 Limited Proteolysis. Limited proteolysis occurs in proteins that undergo 
protein secretion, hormone processing and enzyme activation (Fuller et al., 1988). 
Limited proteolysis often happens through the action of proteases which act sequentially 
or at different levels of a cascade in a given biological phenomenon. For example, limited 
proteolysis can lead to the activation of one enzyme, which in turn activates a subsequent 
target in a cascade. This type of proteolysis usually leads to the sequential activation or 
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termination of a biological process. Some of the classical examples of limited proteolysis 
are the activation of the mating pheromone α-factor by proteolytic processing enzymes in 
yeast, cascades controlling dorsal–ventral fate in drosophila, hemolymph clotting in 
arthropods, complement and blood clotting in vertebrates (Bussey, 1988; Fueller et. al., 
1988; Krem and Cera, 2002). In yeast, the α-factor is synthesized as precursor with a 
molecular mass of 28 kDa. This precursor contains four tridecapeptides. The maturation 
of the α-factor occurs during passage through secretory pathway via limited proteolysis 
catalyzed by a serine proteinase, yscF. The processed form is necessary for the formation 
of diploid yeast cell from two haploid cells.  
In animals, many cascades are controlled by upstream and downstream serine 
proteases. For example the dorso-ventral fate in Drosophila, hemolymph clotting in horse 
shoe crab, and complement and blood clotting in vertebrates consist of a series of 
upstream and downstream serine proteases. These serine proteases undergo zymogenic 
activation sequentially leading to terminal cleavage of substrate by the downstream 
proteases (Fig. 1). The terminal protease in Drosophila leads to activation of a toll 
pathway by activating the toll ligand whereas in horseshoe crab and in vertebrates the 
terminal serine protease cleaves the substrate leading to formation of blood clots. 
1.1.2 Unlimited Proteolysis. Unlimited proteolysis inactivates active proteins 
upon receiving the intra or extra cellular signals. Under various physical and biological 
conditions, the normal half life of proteins vary from a few minutes to over 100 hours 
(Thumm, 1993). The turnover rate of proteins is determined by various physical and 
biological environments. The degradation of proteins is achieved by the action of specific 
exopeptidases or endopeptidases.  
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1.2 Regulation of proteolysis 
Since it plays a vital role in various cellular processes, proteolysis must be strictly 
regulated. Deficiency in proteolytic regulation could lead to serious pathological 
conditions such as cancer, arthritis, neurodegenerative and cardiovascular diseases 
(Sternlicht and Werb, 2001). Proteolysis can be regulated by different mechanisms such 
as:  
1) Specificity of proteases to their substrates  
2) Enzyme activation and inactivation 
3) Tagging  
4) Compartmentalization   
5) Inhibition  
 
1.2.1 Specificity of proteases. Proteases involved in regulatory functions work in 
a concerted manner to process a given substrate. A great portion of proteases do not 
attack substrates at random, but display a high degree of specificity in identification and 
digestion of their substrates. For example, trypsins and chymotrypsins are serine 
proteases with different specificities. The specificity of proteases provides one way to 
avoid unwanted proteolysis. 
1.2.2 Protease activation and inactivation. Another way of regulating 
proteolysis is through protease activation or inactivation. Many proteases such as 
chymotrypsin are synthesized as inactive zymogenic forms that need to be converted into 
active form by proteolytic excision (Khan and James, 1998; Lazure, 2000). For example, 
the inactive chymotrypsinogen is converted to active chymotrypsin by removal of a 
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peptide by trypsin. In addition to cleavage activation, some zymogenic proteases can be 
activated by other ways including binding with other proteins (Friedrich, 2003) or with 
salts (Huang et al., 2001b) or under certain temperature condition (Spiess et al., 1999). 
For example, Staphylococcus aureus, an human pathogen, secretes staphylocoagulase 
which activates prothrombin by binding to the proenzyme. The activity of human 
kallikrein 3 is regulated by salt concentration in vivo. The heat shock protein DegP 
(HtrA) has both molecular chaperone and proteolytic activities. At low temperatures it 
functions as a chaperone and at elevated temperatures it functions as a protease. 
Activation of inactive proteases is an important way to regulate proteolysis that happens 
only in certain conditions or specific developmental stages. 
1.2.3 Tagging. Tagging is one way to regulate proteolysis in a unlimited 
proteolytic process. Tagging is achieved by a molecule called ubiquitin, a 76 amino acid 
protein in all eukaryotes. In a tagging process, a protein that is targeted for degradation is 
covalently linked between a lysine residue of the targeted protein and ubiquitin moiety of 
the ubiquitin molecule.  This covalent linkage is catalyzed by ubiquitin activating 
enzymes.  Once it is tagged, the protein will be degraded by proteosomes. Proteosome is 
a subcellular structure that consists of proteases and other constitutes. For example, the 
yeast 20S proteosome exhibits three distinct proteolytic activities, a chymotrypsin-like, 
trypsin-like and peptidyl glutamyl peptide hydrolyzing activity (Orlowski, 1990; 
Heinemeyer et al., 1991; Tanka et al., 1992). The mammalian cell contains a more 
complex structure called the 26 S proteosome, which contains a 26 S protease with Mr 
1300-1500 kDa as well as other trypsin-like, chymotrypsin-like, and glutamyl proteases. 
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1.2.4 Compartmentalization. Compartmentalization of proteases is another way 
to prevent unwanted proteolysis in a proteolytic process. The two best known 
compartments for proteolysis are vacuole in yeast and lysosome in mammals, both of 
which contain various hydrolytic proteases. The hydrolytic enzymes in each compartment 
belong to aspartic, cysteine, or serine protease families. Targeted proteins are transported 
by various means to these compartments for degradation or for activation. For example, 
the Saccharomyces cerevisiae α-factor receptor (STE3) is transported to vacuole though 
endocytic pathway for degradation (Davis et. al., 1993). Besides vacuole and lysosomes, 
there are other organelles such as endoplasmic reticulum, golgi bodies, peroxisomes that 
also serve as compartments for proteolytic regulations.     
In insects, compartmentalization of digestive enzymes has been observed. The 
midgut lumen is divided into endo- and ectoperitrophic space by the peritrophic 
membrane. Peritrophic membrane is made of protein-carbohydrate matrix. Proteases 
involved in initial digestion are found in the endoperotrophic space. The proteases 
involved in intermediate and final stages of digestion are found in ectoperitrophic space. 
In Rhynchosciara ameircana larvae trypsin and α–amylase are present in midgut cells, 
ecto- and endoperitophic spaces. Aminopeptidases and trehalase are present in midgut 
cells and ectoperitrophic space. The dipeptidases are present only in the midgut cells 
(Terra and Ferreira, 1994).  
1.2.5 Inhibition. Another important way to regulate proteolysis is the inhibition 
of protease activity through the network of protease inhibitors. Protease inhibitors are 
present both inter- and intra-cellularly. The best known examples of protease inhibitors 
present intercellularly are inhibitors in blood. Vertebrate blood contains various serine 
 5
proteases that are involved in blood clotting. The activated enzymes are regulated by the 
action of various inhibitors that are circulating in the blood. In humans, deficiency of 
inhibitors circulating in the blood leads to various clinical disorders. For example 
deficiency of α-1 antitrypsin, a serine protease inhibitor of  neutrophil elastase, leads to 
emphysema. Protease inhibitors found intracellularly are located in the cytoplasm or in 
the nucleus (Grigoryev et al., 1999) and regulate various proteases intracellularly. The 
lysosomes proteases are regulated by protease inhibitors if they are released into the 
cytoplasm (Turk et al., 2002).  The caspases involved in apoptotic pathways are known to 
be regulated by various inhibitors of apoptosis (IAPs) after their release from lysosome. 
The regulation of proteolysis by protease inhibitors has been well documented in 
various insects. For example, melanization is one of the defensive mechanisms adopted 
by insects against various pathogens (Soderhall and Cerenius, 1998). Melanization 
process involves activation of proteases leading to conversion of propeholoxidase (PPO) 
to phenoloxidase. The activated enzyme catalyzes formation of quinones which 
polymerize to form melanin. The quinones and reactive oxygen species produced during 
melanization are toxic to insect cells and microorganisms (Soderhall and Cerenius, 1998). 
Under normal conditions to avoid unwanted production of these reactive molecules, 
insects have evolved various serine protease inhibitors to control the activity of 
proteolytic enzymes (Sugumaran et al., 1985; Aspan et al., 1990; Boigegrain et al., 1992; 
Jiang and Kanost, 1997).  
In Leucophaea maderae, protease activity is found in the posterior half of the 
midgut, whereas the anterior midgut contains protease inhibitor. The biological 
significance of the protease inhibitor in the anterior portion of the midgut is not known 
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(Engelmann et al., 1980). Since, trypsin inhibitors (YIs), subtilisn inhibitors 1 and 2 (SI1, 
and SI2), inhibit endogenous proteases from posterior midgut, it is believed that the 
endogenous inhibitors TIs, SI1, and SI2 act as regulators of proteases that are involved in 
food digestion and possibly protect gut tissues from degradation (Elpidina et al., 2001). 
 
1.3 Proteases 
Proteases are the enzymes that catalyze the irreversible breakdown of peptide 
bonds in proteolysis (Table 1). Based on functional groups present at the active site and 
on the catalytic mechanism, proteases are classified into four groups: serine, cysteine, 
aspartic, and metalloproteases (Hartely, 1960). According to International Union of 
Biochemistry and Molecular Biology nomenclature (Int. Union Bioch., 1992), 
proteinacious enzymes belong to one of the six recognized groups. The six groups are 
1)oxidoreductases, 2)transferases, 3)hydrolases, 4)lyases,  5)isomerases, and 6)ligases. 
The six groups are further classified into different subclasses based on the type of bonds 
they cleave. Proteases belong to group 3 (hydrolases) and subgroup 4 (peptidases, act on 
peptide bonds) (Int. Union Bioch., 1992). The subclasses of peptidases fall into two sets, 
exopeptidases and endopeptidases. Exopeptidases cleave scissile bond proximal to amino 
or carboxy terminus of substrate whereas endopeptidases cleave internal scissile bonds of 
substrate. Based on the amino acid sequences, proteases are classified into different 
families (Rawlings and Barrett, 1993). A family is a group of peptidases that are related 
evolutionarily and have similar primary structure. Each family of peptidases are assigned 
with a code letter denoting the type of catalysis, i.e., S, C, A, M, T or U for serine, 
cysteine, aspartic, metallo, threonine- or unknown type, respectively. These families are 
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further subdivided into "clans" to accommodate sets of peptidases that have a common 
ancestor (Rawlings and Barrett, 1993). Presently there are more than 30 families of 
serine-, cysteine-, and metallo-proteases and a few families of aspartic-, threonine- and 
mixed- proteases (Barrett, 1999; Merops database). The families for known proteases are 
summarized in Table 2A-F. 
1.3.1 Serine Proteases. Serine proteases are one of the most important protease 
super-families. Serine proteases are found in all organisms studied so far and carry out 
various physiological functions, such as digestion, defense, and protein activation 
(Yousef et al., 2003). Serine proteases are characterized by the presence of a serine 
residue at the active site.  Based on primary structural homology, serine proteases are 
grouped into more than 20 families and each of these families is further subdivided into 
several clans. Members in each clan have a common ancestor (Rawlings and Barrett, 
1993) (Table 2A). The primary structures of four clans including  chymotrypsin (SA), 
subtilisin (SB), carboxypeptidase C (SC), and Escherichia D-Ala-D-Ala peptidase A (SE) 
are totally unrelated, suggesting at least four separate evolutionary origins for serine 
proteases. The clans SA, SB, and SC consists of a common catalytic triad of three amino 
acids, serine (nucleophile), aspartate (electrophile), and histidine (base) and have a 
common reaction mechanism. The three catalytic triads of the three clans are oriented in 
a similar manner, but the protein folds are quite different, indicating that these proteases 
have undergone convergent evolution over a period of time. The catalytic mechanisms of 
clans SE and SF (repressor LexA) are different from those of clans SA, SB, and SE, since 
they lack the classical Ser-His-Asp triad. Another interesting feature of serine proteases is 
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the conservation of glycine residues in the vicinity of the catalytic serine residue to form 
the motif Gly-Xaa-Ser-Yaa-Gly (Brenner, 1988). 
1.3.2 Insect Serine Proteases. In many insects, serine proteases are the major 
digestive and regulatory enzymes (Applebaum, 1985; Terra and Ferreira, 1994). Among 
serine proteases, trypsin and chymotrypsin have important role in dietary protein 
digestion (Terra and Ferreira, 1994). Protein digestion occurs in insect midgut epithelium. 
Initially the proteins are cleaved into oligomers by serine proteases in the 
endoperotrophic space of ventriculus. These oligomers are further hydrolyzed by action 
of exopeptidases in the ectoperitrophic space and on microvillar membranes. The di- and 
tripeptides generated are cleaved by dipeptidases that are present in the midgut cells and 
glycocalyx. Trypsins and chymotrypsins are observed in midgut from various orders of 
insect which include Coleoptera, Diptera, Dictyoptera, Heteroptera, Hymenoptera, 
Lepidoptera, Orthoptera, Thysanura, (Gooding and Rolseth, 1976; Jany et al., 1978; 
Baker, 1981; Briegel, 1985; Sakal et al., 1988; Ferreira and Terra, 1989; Baumann, 1990; 
Christeller et al., 1990; Graf and Graf et al., 1991; Johnston et al., 1991; Lemos and 
Terra, 1992; Zinker and Polzer, 1992; Schumaker et al., 1993; Ferreira et al., 1994; Zhu 
et al., 2005; Volpicella et al., 2003; Zhu et al., 2003a). In contrast to vertebrate trypsins, 
insect trypsins are not activated by calcium ions (Levinski et al., 1977; Jany et al., 1978; 
Johnston et al., 1991; Lemos and Terra, 1992). Insect trypsins are unstable in acidic pH 
(Miller et al., 1974; Ward et al., 1975; Jany et al., 1978; Sakal et al., 1989) with the 
exception of some enzymes from Musca domestica and Ostrinia nubilalis (Lemos and 
Terra, 1992; Bernardi et al., 1996). Serine proteases with elastase specificity are less 
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studied in insects. Presence of elastase like enzymes is documented by Christeller et al., 
(1989), Christeller et al., (1992), Valaitis (1995).  
 
1.4 Protease inhibitors  
 
Protein protease inhibitors are polypeptides that inhibit the action of proteases 
(Laskowski and Kato, 1980, Travis and Salvesen, 1983). The existence of protease 
inhibitors in nature was first reported by Fermi and Pernossi (Birk, 2003). Protease 
inhibitors are widely distributed in various tissues of animals, plants and microorganisms 
(Laskowski and Kato, 1980). In plants protease inhibitors are found to be induced in 
response to insect attack (Ryan, 1990). Individual inhibitors inhibit proteases of their 
mechanistic class identified by Hartley (1960) except α2-macroglobulins which inhibit 
proteases of all classes. Accordingly, protease inhibitors are divided into 4 major 
mechanistic classes: inhibitors of serine proteases, inhibitors of cysteine proteases, 
inhibitors of aspartic proteases and inhibitors of metalloproteases. The protease inhibitors 
of these mechanistic classes are further classified into different families. 
1.4.1 Classification of Protease Inhibitors. Originally protease inhibitors are 
grouped into 9 families based on amino acid sequence homology, topological 
relationships between disulfide bonds and the location of reactive sites (Laskowski and 
Kato, 1980). With the discovery of new protease inhibitors, the protease inhibitor 
families were expanded. Following the Laskowski and Kato (1980) homology criteria, 
Reeck et al., (1997) made a complete list and grouped inhibitors into 22 families (Table 
3). Individual families are identified by a prominent member of that family without 
 10
considering functional and biological source. According to this classification, inhibitor 
families include members that may inhibit proteases of different mechanistic class, so 
called “cross class” inhibitors. The specificity of inhibitors largely relies on the exposed 
reactive-site loop (Laskowski and Kato, 1980; Laskowski, et al. 1987). The sequence of 
reactive site loop is highly variable whereas the scaffolding structure that supports the 
loop is quite conserved. The combination of a variable loop and a conserved scaffolding 
structure appears to be the basis for inhibitory selectivities, which is supported by the fact 
that differences in reactive-site loop sequence of turkey ovomucoid lead to differences in 
selectivities of the inhibitors (Bigler et al., 1993).  
Protease inhibitors exist in different tissues and stages of organisms from 
bacterium to humans. Among the four mechanistic classes of protease inhibitors, namely 
serine, cysteine, aspartic and metallo protease inhibitors, serine protease inhibitors are 
most widely studied. According to the above classification, 15 out of 22 families are 
serine protease inhibitors. The 15 families of serine protease inhibitors are:  
1.4.2 Bovine pancreatic trypsin inhibitor (Kunitz) family. The pancreatic 
trypsin inhibitor identified from bovine is a typical example of this family. This is the 
first inhibitor whose sequence and three dimensional structure of free enzyme and 
enzyme-inhibitor complex was determined. The inhibitors of this family contain four to 
eight disulfide bonds and two inhibitory domains. Inhibitors with two inhibitory domains 
are called double headed inhibitors. The inhibitors of this family have been found from 
humans, bovine, pig, birds, snails, and from snake venom.  
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1.4.3 Kazal serine protease inhibitor family. Secretory pancreatic trypsin 
inhibitor (Kazal type), an initial member of this group, is found in both vertebrates and 
invertebrates. The inhibitors belonging to this group have one to many reactive site 
domains. The number of disulfide bonds vary from 3 (bovine pancreatic tryspin inhibit) 
to 20 (avian egg white ovoinhibitor) (Laskowski and Kato, 1980).  
1.4.4 Soybean trypsin inhibitor (Kunitz) families. Members in the Soybean 
trypsin inhibitor (Kunitz) families contain a single inhibitory domain that inhibits single 
protease molecule. This type of protease inhibitors have been called single-headed. The 
inhibitor in this family contains two disulfide bonds. In most soybean trypsin inhibitor 
kunitz family the P1 is usually arginine.  
1.4.5 Bowman-Birk inhibitors (BBI). Bowman-Birk inhibitors are isolated from 
all leguminous plants. BBIs usually have two inhibitory domains that can inhibit two 
protease molecules. They are ~70 amino acids in length and contain 7 disulfide bonds. 
BBIs are potent inhibitor of insect digestive trypsins and chymotrypsins (Levinsky et al., 
1977; Sakal et al., 1989). Suzuki, et al., (1987) described structure of BB type protease 
inhibitor from peanuts. The inhibitor is tetramer and each monomer consists of two 
distinct domains. The inhibitor consists of two protruding sites that independently bind to 
two protease molecules. Under reduced conditions, the inhibitors lose 3-D structure but 
retain some inhibitory activity (Godbole et al., 1994).   
1.4.6 Potato inhibitor I family. This family is also referred to as chymotrypsin 
inhibitor I because they inhibit chymotrypsin very strongly. The inhibitors of this group 
are noncovalent tetramers with four different subunits. The molecular mass of each 
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subunit is 10 kDa. Each subunit consists of one intra chain disulfide bond (Melville and 
Ryan, 1972). The tetramer binds four chymotrypsin molecules thus each subunit possess 
one chymotrypsin binding site.  
1.4.7 Potato inhibitor II family. The molecular weight of the inhibitor is 20 kDa. 
The inhibitor is a dimer and each subunit has two binding sites for chymotrypsin. The 
inhibitor II preparations from different potato varieties are immunologically related 
(Ryan and Santarius, 1976). There is no consensus observed in the reactive site sequences 
of this family of inhibitors.  
1.4.8 Squash inhibitor family. The inhibitors of this family are small molecular 
weight proteins ~3000 Da (Wieczorek et al., 1985). They consists of 27-33 amino acids 
residues and are cross-linked by three intra disulfide bonds. The reactive site peptide 
bond is located between amino acid residue 5 and 6. The inhibitors of this group are 
highly stable and rigid proteins. Due to rigid nature of the proteins, the structure is 
distorted and contains triple stranded antiparallel β sheets (Otlewski and Krowarsch, 
1996).  
1.4.9 Barley trypsin inhibitor family. The prototype of this group is barley 
trypsin inhibitor which is of 13 kDa protein and contains five disulfide bonds (Odani et 
al., 1983). The anionic and cationic inhibitors isolated from buckwheat seeds are highly 
pH and thermostable (Belozersky et al., 2000). The inhibitors of this group inhibit trypsin 
and to certain extent they inhibit chymotrypsin too.  
1.4.10 Ascaris trypsin inhibitor family. The most striking characteristic of this 
family is the universal presence of ten cysteine residues that form five disulphide bonds. 
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Two disulfide bonds are located on either side of the reactive-site loop. The inhibitors 
contain two β sheets and each β sheet is composed of two antiparallel strands (Grasberger 
et al., 1994; Duggan et al., 1999). They lack true hydrophobic core. The reactive-site 
residues are hypervariable, and this hypervariability is due to the selective pressure 
brought by their host cognate enzymes (Hawley and Peanasky, 1992; Lu et al., 1998). 
Well characterized insect inhibitors that belong to this group are chymotrypsin inhibitors 
(AMCI) 1 to 3 isolated from larval hemolymph of Apis mellifera. 
1.4.11 Locust inhibitor family. Members of this group are ~35-residues long and 
consist of three antiparallel β-strands stabilized by three disulfide bonds. The protease 
binding loop is located near the C-terminus and is flanked by two disulfides bonds. Well-
characterized inhibitors of this family are from the migratory locust, Locusta migratoria 
and the desert locust, Schistocerca gregaria. The inhibitors are found in many tissues 
example the brain, fat body, ovaries of the insects (Simonet et al., 2005). 
1.4.12 Ecotin family. Ecotin is the primary member of this family of inhibitors. 
Ecotin is a Escherichia coli periplasmic protein of 142 amino acids (McGrath et al., 
1991). It consists of two β sheets that are sandwiched. It is a potent inhibitor of serine 
proteases that have wide substrate specificities. Each individual molecule of ecotin 
interact C-terminally to form a dimer. The dimer binds two protease molecules. Ecotin 
monomer consists of one disulfide bond near to the reactive site loop that provides 
stability to the molecule.  
1.4.13 Serpin family. Serpins are found in both prokaryotes and eukaryotes 
(Potempa et al., 1994; Silverman et al., 2001). Their secondary structure consists of three 
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β- sheets, nine -helices, and a reactive site loop (RSL) which confers specificity to 
protease recognition (Huber and Carrell, 1989; Crowther et al., 1992). The RSL is 
composed of ~17 amino acids. The RSL is a flexible region and is capable of distorting 
target protease upon entering into the enzymes active site.  
1.4.14 Streptomyces subtilisin inhibitor family Streptomyces subtilisin 
inhibitors (SSI) are found widely in Streptomyces species. They exhibit inhibitory activity 
against both subtilisin BPN' and trypsin. The SSI is a dimeric molecule of identical 
subunits and is a 23 kDa protein (Takahashi and Fukada, 1985). The two subunits interact 
with two protease molecules. 
1.4.15 Hirudin family. Hirudin is a potent thrombin inhibitor belongs to this 
family. Hirudin is a 65 amino acids protein with Mr of ~7000 Da. Hirudin consists of an 
N-terminal globular domain and an extended C-terminal domain. The N-terminal 
residues 1-3 form parallel β-strand with 214-217 residues of thrombin. The C-terminal 
domain makes numerous electrostatic interactions with the exosite of thrombin. The last 
five residues at C-terminal are in a helical loop. They form many hydrophobic contacts 
with thrombin (Rydel et al., 1990). 
1.4.15 α-2-Macroglobulin family. Human α-2-macroglobulin, the major plasma 
protein belongs to this family. It contains four polypeptide subunits. Each subunit is 180 
kDa. Each subunit consists of a bait region of 25-30 amino acid residues and a thioester 
bond, both located in the middle of the subunit. These two sites play important role in 
inhibiting the proteases (Sottrup-Jensenn and Birkedal-Hansen, 1989). 
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1.5 Diversity in proteases and protease inhibitors 
Due to their roles in various biological processes, there is an increasing interest in 
the identification and functional characterization of proteases that are present in various 
organisms. At least 5% of the human genes codes for proteolytic process components 
including its proteases, inhibitors and cofactors (Richard, 2005). The Merops, a protease 
database, lists 461 proteases and homologues in human, 363 in C. elegans, 513 in 
Drosophila, 383 in Mus musculus, and 227 in Rattus norvegicus (Table 3) (López-Otín and 
Overall, 2002). Up to now, only a tiny portion of these protease are studied. The protease 
map of murine is similar to the human map, but protease families, kallikreins, cathepsins 
or matrix metalloproteases (MMPs) have evolved differently (Balbin et al., 2001; Yousef 
and Diamandis, 2001; Deussing et al., 2002) (Table 4). The Drosophila melanogaster 
gene content is considerably lower than vertebrate organisms, but a similar number of 
protease genes to that of humans are identified in the fly genome. Studies are needed to 
clarify the genetic, functional and evolutionary differences between the protease 
repertoires of these organisms. In addition to the universal job of proteolytic cleavage that 
is common to all organisms, there are many proteases that carry specific functions in 
different organisms. Studies in this field will uncover diverse new proteolytic substrates 
and new endogenous inhibitors that have the ability to regulate protease activity in 
physiological and diseased conditions.  
Like proteases, protease inhibitors also occur widely in nature and are known to 
regulate various functions ranging from cell activity to cell death (Dickinson et al., 1995; 
Armstrong et al., 1996). Of the total genes identified in the genome, the inhibitors 
account for about 0.75% and 1.17% in Drosophila and humans respectively (Merops 
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database, July 25th 2005). In Anopheles gambiae, the inhibitors accounts for about 0.62%.  
The Merops database contains about 3690 inhibitor proteins that are grouped into 
different families. Of the four known class of protease inhibitors, serine protease 
inhibitors are known to participate in highly diversified actions in regulating proteolysis.  
 
1.6 Insect protease inhibitors  
As in other organisms, protease inhibitors are believed to occur abundantly in 
insects (Eguchi, 1993). Of the four mechanistic classes of inhibitors, serine protease 
inhibitors are more extensively studied in insects and will be reviewed in more detail 
later. For the other three mechanistic classes of inhibitors, only a few have been identified 
from a number of insects. These include several cysteine protease inhibitors from 
Drosophila, Sarcopgaha, Spodoptera, Trichoplusia, and Bombax, which are found to 
participate in insect defense, to block apoptosis, and to involve in pupal diapause (Suzuki 
and Natori, 1985; Yamamoto, 1999; Meier et al., 2000; Huang et al., 2001a; Goto and 
Denlinger, 2002; Liao et al., 2002; Liu and Chejanovsky, 2003). In addition, a few 
metalloprotease inhibitors have been identified from Galleria melonella and Drosophila 
(Wedde et al., 1998; Pohar et al., 1999). The immune response related inhibitor, IMPI 
from Galleria melonella is the first metalloprotease identified from insects. To date, no 
aspartic protease inhibitor has been identified from insects. A list of inhibitors identified 
from different insect species is presented in the Table 5.  
1.6.1 Insect serine protease inhibitors. Serine protease inhibitors identified from 
different insects are known to perform diverse functions. The insect inhibitors identified 
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or partially characterized from the insect hemolymph belong to either low molecular 
weight proteins (Ramesh et al., 1988; Boigegrain, et al., 2000; Frobius et al., 2000; 
Gáspári et al., 2002; Shrivastava and Gosh, 2003) and or the serpin family (Kanost, 1990; 
Cherqui et al., 2001). The hemolymph inhibitors regulate the activity of serine proteases 
involved in prophenoloxidase cascade and also play a role in insect defense against 
pathogens and injury. Examples for low molecular weight inhibitors in insect hemolymph 
are the inhibitors identified from the pupa of housefly, Musca domestica L., which are 
heat-stable low molecular weight peptides and are potent phenoloxidase inhibitors 
(Tsukamoto et al., 1992). HiTI, a 7 kDa protein from the fly, Haematobia irritans 
irritans, contains a single Kunitz type domain and is known to play a role in 
antimicrobial defense (Azzolini et al., 2004). For serpin inhibitors, Manduca sexta 
hemolymph contains different isoforms of serpins. These serpins regulate the 
prophenoloxidase activation pathway in the hemolymph (Kanost et al., 1989; Kanost, 
1990; Zhu et al., 2003b; Wang and Jiang, 2004; Tong and Kanost, 2005). The Locusta 
migratoria inhibitors (LMCI I and II) and the Mythimna unipuncta trypsin (MTI) and α–
chymotrypsin (MCI) inhibitors also inhibit prophenoloxidase activation cascade 
(Boigregrain et al., 1992; Cherqui et al., 2001).  
In addition to hemolymph inhibitors, serine protease inhibitors in other tissues 
with different functions have also been identified. The Kunitz-type cocoon shell-
associated trypsin inhibitor (CSTI), is present in the silk of Bombax mori prevents 
inappropriate degradation of silk proteins during their secretion (Kurioka et al., 1999). 
Serine protease inhibitors in the midgut regulate midgut proteases of many insects 
(Gatehouse and Gatehouse, 1998; Elpidina, 2001; Kellenberger et al., 2003). Inhibitors 
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isolated from Rhodnius prolixus and Dipetalogaster maximus prevent blood clotting once 
injected into the hosts (Friedrich et. al., 1993; Lange et al., 1999; Francischetti et al., 
2000; Campos et al., 2002; Schlott et al., 2002) and thus helps insects in feeding blood. 
The anti-hemostatic activity of thrombostatin plays an important role in maintaining the 
ectoparasitic lifestyle of horn flies (Zhang et al., 2002). Protease inhibitors are also 
components are venom. A protease inhibitor isolated from bee venom is highly stable at 
low pH and does not contain any SH groups (Shkenderov, 1973). The purified inhibitor 
inhibits trypsin and possibly play protective role of bee venom components from 
proteases of stung man or animal.   
Some insect inhibitors are known to contain high cysteine residues. For example, 
the Apis mellifera cathepsin/chymotrypsin inhibitors 1-3 (AMCI 1-3) isolated from larval 
hemolymph belong to Ascaris family (Bania et al., 1999). The AMCI-1 inhibits both 
chymotrypsin and Cathepsin-G. All three isoforms contain 10 cysteine residues and lack 
tryptophan, tyrosine, and histidine. The major isoform AMCI-1 is a single-chain protein 
whereas AMCI-2 and -3 are two-chain proteins. The reactive site of inhibitors is Met30-
Gln31. All the three inhibitors are 44% identical to Ascaris trypsin isoinhibitor (ATI) and 
belong to Ascaris family. NMR studies shows that AMCI-1, consists of two 
perpendicular sheets, several turns and a loop that host a protease binding site (Cierpicki 
et al., 2000).  The Drosophila seminal fluid protein, Acp62F, is a trypsin protease 
inhibitor (Lung et al., 2002). It contains 10 cysteine residues that are highly conserved 
with Ascaris members. It is proposed that it could play a role in reducing the female life 
span. The Anopheles gambiae genome contains a few uncharacterized protease inhibitors 
that belong to Ascaris family. The Galleria melonella metalloprotease inhibitor, IMPI, 
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belongs to Ascaris family and contains 10 cysteine residues (Wedde et al., 1998; 
Clermont et al., 2004). The peptides SGCI, SGTI, PMP-D2 and PMP-C, isolated from 
locusts contain 6 cysteine residues that three intramolecular disulfide bonds. The peptide 
PMP-C contains a fucose moiety (Nakakura et al., 1992; Gaspari et al., 2002).  
Given the abundance of insect species and only a small portion of protease 
inhibitors have been identified from a few insect species. There are lots of opportunities 
to identify new protease inhibitors which have great potential in understanding basic 
biology as well as practical applications. 
 
1.7 Action of serine proteases and inhibition mechanism  
The amino acid sequence analysis and X-ray crystallographic studies of many 
serine proteases have shown that the catalytic site lies in the cleft on the surface of 
enzyme molecule. The substrate chain lies along the active site cleft. There are subsites 
that adapted to bind amino acid side chains of a substrate on either side of active site cleft 
(Fig. 2). Individual subsites of an enzyme (….S3, S2, S1, S1’, S2’, S3’….) and the 
complementary part of a substrate (…..P3, P2, P1, P1’, P2’, P3’….) are named according to 
Berger and Schechter, (1970). In the center of the cleft is the catalytic triad consisting of 
His 57, Asp 102 and Ser 195 (chymotrypsinogen numbering). During catalysis, the initial 
step is to form an acyl enzyme intermediate between the substrate and serine residue at 
the active site of the enzyme. This covalent complex proceeds via negatively charged 
transition state to form a tetrahedral intermediate. During deacylation, the acyl-enzyme 
intermediate is hydrolyzed by a water molecule to release cleaved peptide and restores 
the Ser-hydroxyl of the enzyme (Fastrez and Fersht, 1973).  
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If a protein can interact with the active site of a protease in a manner similar to  a 
substrate and block (or slow down) the activity of this protease, then this protein is called 
a protease inhibitor. According to Laskowski and Kato, (1980), the inhibition mechanism 
by which inhibitor suppress protease activity by acting as substrates of their target 
enzymes is referred to standard mechanism. Inhibitors that follow standard mechanism 
have a similar reactive site loop configuration. The loop consists of a scissile bond 
between two amino acid residues P1 and P1’ on the substrate (Fig. 2). P1 residue at the N-
terminal end can either be lysine/arginine in trypsin inhibitors. In chymotrypsin inhibitors 
the P1 residue could be either Tyr/Trp/Phe/Leu/Met. In elastase the P1 residue  is 
alanine/serine. P1’ residue is located adjacent to P1 by a scissile bond. The inhibitors that 
obey standard mechanism encompass at least one disulfide bond at the reactive site 
peptide bond (Fig. 3). This ensures close proximity and no dissociation of two peptide 
chains when virgin inhibitor converted to cleaved inhibitor. 
Laskowski and Kato (1980) gave the overall mechanism of enzyme-inhibitor 
interaction (Fig. 4). In their model, the enzyme and inhibitor interact to form a stable 
complex (C) with relatively small conformational change. This stable complex 
dissociates very slowly to give free enzyme and virgin (I) or cleaved inhibitor (I*). In I* 
the scissile bond at P1-P1’ is cleaved. The enzyme and inhibitor interact predominantly in 
a canonical fashion. In complexes with their cognate enzymes, the reactive site loop of 
the inhibitor associates with catalytic residues in a similar way as that of bound substrates 
(Fig. 5). In trypsin like proteases, the segment amino terminal of the scissile bond of the 
inhibitor fits in to the enzyme as an antiparallel β-strand. This is facilitated through main 
chain hydrogen bond formation between P3 and P1. The flanking carboxy terminal 
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residue at P2’ position interacts to form one more hydrogen bond. Under this condition, 
the inhibitor reactive site is in close proximity to catalytic residues of the protease. The P1 
carbonyl carbon forms contact with Ser195 Oγ through van der Waals interaction. The 
carbonyl group of P1 projects in to the oxyanion hole to form two hydrogen bonds with 
Gly 193N and Ser195N (Bode and Huber, 1992). The scissile peptide bond remains 
intact. The exposed P1 residue of the inhibitor gets buried in the S1 specificity pocket of 
the enzyme which is hydrophobic. The interaction of the P1 side chain with S1 specificity 
pocket are energetically most important and this determines the specificity of a given 
inhibitor for a particular protease. Inhibitors have ability to tolerate replacement of P1 
residue and still retain inhibitory activity either with retention of original specificity (eg. 
Arg         Lys or Leu         Met) or with change in specificity from tryptic to chymotryptic 
after Arg       Phe replacement. The residue at P2 position in all active inhibitors is neutral. 
In most inhibitor families, the P1’ position can tolerate broad range of residues with the 
exception that serine proteases rarely hydrolyze bonds with P1’ Pro. Inhibitors with P1’ 
Pro are not active (Qasim et al., 1995). 
 In addition to the primary interactions, the exposed side chains of residues around 
reactive site (P9 to P4’) make hydrophobic interaction with protease subsites to form 
inhibitor-protease complex. The complex formation is accompanied by slight 
conformational changes which freezes the binding loop of the inhibitor. This change is 
essential to form tight, rigid and energetically favorable inhibitor-protease complex. The 
stable complex acts as energy sink which dissociates very slowly to give free enzyme and 
cleaved inhibitor. 
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Exceptions to the standard mechanism are α2-macroglobulin, ecotin and serpins. 
α2-macroglobulin inhibits the serine proteases by engulfing the proteinase after cleavage 
of α2-macroglobulin molecules by their target enzymes (Sottrup-Jensen and Birkedal-
Hansen, 1989). Ecotin, a non-canonical inhibitor from E. coli inhibits proteases that have 
wide specificities. Each ecotin homodimer inhibits two enzyme molecules. It has a less 
typical substrate like primary site and an antibody like secondary site, which allows 
inhibitor to bind tightly to proteases and to block the substrate binding site (McGrath et 
al., 1995). The primary site interactions that are less optimal are compensated by the 
additional secondary site interactions. Serpins to certain extent are canonical inhibitors. 
Serpins employ suicide substrate inhibition mechanism. The actions of the protease, both 
in initial recognition and in subsequent steps, are of a serine protease acting on a substrate 
peptide bond to cleave it. However, in serpin, the two chain form is not inhibitory 
because of the conformational changes. Initially, the proteinase recognizes the reactive 
bond on the reactive center loop (RCL) of serpin as a potential substrate to form 
Michaelis complex (Ye et al., 2001; Dobo’ and Gettins, 2004). The protease sits on top of 
serpin RCL and the side chain of P1 residue resides in the protease specificity pocket. The 
scissile bond in the RCL is cleaved and the catalytic serine residue in the protease is 
acetylated. The RCL inserts into the β-sheet A of serpin molecule. The protease 
undergoes translocation from top of serpin to bottom of serpin molecule to form stable 
serpin-protease complex (Dobo’ and Gettins, 2004) (Fig. 6).  
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1.8 Structural characteristics of serine protease inhibitor families 
 Protease inhibitors are rigid and stable molecules. Most of the inhibitors are 
competitive inhibitors and form tight complex with proteases. Inhibitors of different 
mechanistic class contain β-sheet and α-helices. The number of β-sheet and α-helices 
vary among different mechanistic class. Inhibitors with single polypeptide chain 
(monomer), two polypeptide chains (dimer) and many polypeptide chins (multimer) exits 
in nature. For, example, potato inhibitor II is a dimer and potato inhibitor I and α2-
macroglobulin are tetramers. The inhibitor consists of a reactive site domain that forms a 
loop which fits into the enzyme specificity pocket. The length of reactive site domain 
varies depending on the size of the inhibitor molecule. It may vary from a few residues 
such as in Cucurbita maxima trypsin inhibitor to forty five residues such as in serpins 
(Jiang et al., 1994). The number of reactive site domains varies in each inhibitor 
molecule. An inhibitor of single polypeptide chain may contain one to several reactive 
site domains. Based on the number of reactive site domains in the inhibitor molecule, 
they may be referred to as single headed if they contain one reactive site domain, double 
headed if they contain two reactive site domains and so on. The single headed inhibitor 
inhibits one enzyme molecule, like wise double headed can inhibit two molecules of the 
same or different enzymes. 
 The gene size and coding regions of protease inhibitors are generally small except 
in some cases of inhibitors that belong to serpin family, macroglobulin family, cysteine 
and metallo protease inhibitor families. The genes contain no to a few introns and many 
inhibitors are multigene families (Boulter, 1993; Ryan, 1990). The double and multi-
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headedness of protease inhibitors have arisen by gene duplication and gene elongation 
and in some cases by gene fusion (Laskowski and Kato, 1980). 
 Of the protease inhibitors, the structures of canonical inhibitors of serine proteases 
have been studied extensively. Canonical inhibitors are proteins that range in size from 
29 to 190 amino acids. Majority of inhibitors are purely β-sheet or mixed α/β proteins. 
They can also be α-helical or irregular proteins rich in disulfide bonds. The most striking 
feature of canonical inhibitor families is that the reactive site loops are very similar even 
though the P3-P3’ segment is different among different families. Figure 7A-C shows 
inhibitors belonging to different families have an exposed binding loop which is unique 
to canonical inhibitors (Bode and Huber, 1992). The loop is highly flexible in 
uncomplexed state and becomes rigidified upon complex formation. The structures 
outside the binding loop posses different folding motifs (β-sheets and α-helices). The 
loop which is primary binding segment between the framework anchoring points has a 
flat shape that fits into the active-site cleft of cognate proteases. The inhibitors have 
compact shape and contain a hydrophobic core which in some cases formed by cross 
connecting disulfide bonds. The stability of uncleaved inhibitor domain towards 
unfolding is high. The disulfide bonds stabilize the inhibitor and the extent of 
stabilization depends on the number of thiol groups that form disulfide bond under native 
state.  
 
1.9 Wheat production and Hessian fly 
Wheat (Triticum aestivum L. em. Thell) is the national staple food staple of 43 
countries and provides approximately 20% of the total calories for the people of the 
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world. The total acreage of wheat grown annually in U.S varies between 50 and 80 
million acres.  One of the major challenges to wheat production is yield loss and quality 
reduction caused by insects and diseases. 
Among various pests of wheat, Hessian fly is one of the major insect pests. The 
Hessian fly was introduced into the United States by Hessian soldiers in 1776 (Gagne and 
Hatchett 1989) and it occurs in all major wheat growing regions of the United States 
(Ratcliffe and Hatchett, 1997). The annual loss from the Hessian fly infestation to the U. 
S. farmers is up to 5-10% of the wheat crop per year (Hatchett et al., 1987). In addition to 
wheat, the Hessian fly also damages barley, rye and Triticale. The insect damages the 
plant by sucking the plant juice. The ingested juice enters the insect gut where the juice 
constituents are degraded by action of various proteases. Protease activity in the gut was 
detected by Shukle et al., (1985). Recently Zhu et al., (2005) also showed the presence of 
serine protease activity in the gut of Hessian fly. Fifteen trypsin and chymotrypsin 
cDNAs have cloned and characterized. The initial protease activity and protease gene 
identification in Hessian fly indicate that there is a complex of protease network like that 
in other organisms. Understanding the regulation of this complex network of proteases 
and the regulation of proteolysis by protease inhibitors in the Hessian fly will not only 
contribute to the basic understanding of the proteolysis process, but may also have 
practical application such as finding new ways to manage this insect pest. Identification 
and characterization of proteases and protease inhibitors is the first step to understand the 
proteolytic system and its regulation. To date no protease inhibitors have been identified 
from the Hessian fly. My research focuses on identification and molecular 
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characterization of cDNAs encoding protease inhibitors from the Hessian fly. My results 
will provide a basis to reveal the proteolytic system and its regulation in the future. 
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Figure 1: Serine protease cascade controlling (a) dorso-ventral polarity in Drosophila (b) 
hemolymph clotting in horseshoe crab (c) complement activation and (d) blood clotting 
in vertebrates. Square colored boxes represent zymogenic serine proteases. Colored oval 
shapes denote active serine proteases. Upstream proteases activate downstream proteases 
and substrates below them. Dashed boxes and ovals represent non-serine protease 
substrates and cleavage products. Adopted from Krem and Cera (2002).
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Figure 2: Schematic representation of specificity subsites of proteases and the 
corresponding complementary sites of substrates. The subsites of proteases, S1, S2, S3… 
are away from the active site towards N-terminus. S1’, S2’ and S3’ are towards C-
terminus. Arrow indicates the cleavage site. Substrate sites corresponding to subsites of 
enzymes P1, P2, P3…. are towards N-terminus. P1’, P2’, P3’……. are towards C-terminus. 
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Figure 3: Schematic representation of inhibitor reactive site. I - represents the virgin 
inhibitor, I* - represents the cleaved inhibitor. Arrow in the virgin inhibitor represent the 
peptide bond cleavage site between P1-P1’ residues. The reactive center site in the virgin 
inhibitor is encompassed by disulfide bond. The two peptide chains of cleaved (I*) 
inhibitor is secured by disulfide bond. 
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H3N+….. Cys  P5 P4 P3 P2 P1                                   P’1 P’2 P’3 P’4 P’5Cys ……COO-
Virgin Inhibitor - I 
        S                                                                                          S 
 
 
 
 
 
H3N+….. Cys P5 P4 P3 P2 P1-COO-                +HN-P’1 P’2 P’3 P’4 P’5 Cys ……COO-
Cleaved Inhibitor – I* 
        S                                                                                          S 
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Figure 4: Enzyme-inhibitor interaction. Figure adopted from Laskowski and Kato (1980). 
E-enzyme, I and I* - virgin and modified inhibitors, L and L* - loose, noncovalent 
complexes of E with I and I* respectively, C-stable enzyme inhibitor complex, X-long 
lived intermediate in the E+I* reaction 
 
 
E + I                    L                    C                   X                 L*                         E   +  I*
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Figure 5: Complex formation between trypsin and ovomucoid inhibitor. Adopted from 
Bode and Huber (1992). The reactive site loop spans between scaffold-anchored pillars. 
The inhibitor is connected to its molecular core through intra disulfide bond and other 
spacer elements. The inhibitor is bound similarly as that of substrate (shown in bold line) 
through hydrogen bonds forming an antiparallel β-structure between P1-P3 of inhibitor 
and 216 to 218 of protease. The catalytic Ser195 Oγ is in contact with P1 carbonyl carbon 
of inhibitor through van der Waals forces.  
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Fig. 6: The branched pathway mechanism of serpins. Figure adopted from Dobo’ and 
Gettins, (2004). E–Protease, I–serpin, EI-noncovalent Michaelis-like complex, EI’-
covalent acyl-enzyme intermediate, E-I*-covalent complex (E-I*), I*-cleaved serpin (I*). 
k1, k-1, k2, k3, k4, and k5 are rate constants. Reactive center loop of serpin - solid black 
color. 
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Figure 7: Ribbon model of canonical inhibitors showing the similar reactive site loop. 
Adopted from Bode and Huber (1992). A- Ribbon model of pancreatic basic trypsin 
inhibitor. Semisynthetic arginine15 is shown on the binding loop. Inhibitor consists of 
three stranded β–sheet and a C-terminal α-helix that form the core. 
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Figure 7: Ribbon model of canonical inhibitors showing the similar reactive site loop. 
Adopted from Bode and Huber (1992). B-Ribbon model of eglin c. Semisynthetic leucine 
45 (P1) and arginine 46(P1’) is shown on the binding loop. The inhibitor consists of four 
stranded mixed antiparallel (β1, β4, β3) and parallel (β3, β2) β-sheet forms the core. 
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Figure 7: Ribbon model of canonical inhibitors showing the similar reactive site loop. 
Adopted from Bode and Huber (1992). C-Ribbon model of squash seed inhibitor-
1(CMTI-1). The semisynthetic arginine 5 (P1) and isoleucine 6 (P1’) is shown on the 
loop. It consists of two stranded β-ladder. 
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Table 1: Specificity of Proteases. Adopted from Rao et al., (1998). 
   Enzyme Peptide bond cleaved 
Trypsin 
Chymotrypsin, subtilisin 
Staphylococcus V8 protease 
Papain 
Thermolysin 
Pepsin 
Lysin (or Arg) ------ 
Try (or Trp, Phe, Met) ------ 
Asp (or Glu)  ------- 
Phe (or Val, Leu)-Xaa --- 
----- Leu ( or Phe) ---- 
-Phe (or Try, Leu) -Try (or Phe, Try) 
 
   Arrow indicates the site action of protease. Xaa any amino acid residue. 
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        Table 2A: Serine protease clans and families. 
 
Clan  Family Example                                                                                             
 
 SA  S1  Chymotrypsin A (Bos taurus) 
   S2  Stretogrisin A 
   S3  Togavirin (Sindbis virus) 
   S6  IgA1-Specific serine endopeptidase (Neisseria gonorrhoeae) 
   S7  Flavivirin (yellow fever virus) 
   S29  Hepatitis C virus NS3 polyprotein peptidase 
   S30  Potyvuris P1 proteinase (plum pox virus) 
S31  Pestivirus polyprotein peptidase p80 (bovine viral diarrhea virus 1) 
S32  Equine arteritis virus serine endopeptidase (Equine arteritis virus) 
 S35  Apple stem growing virus protease 
 
 SB  S8  Subtilisn (Bacillus licheniformis) 
  
 SC  S9  Prolyl oligopeptidase (Sus scrofa) 
   S10  Carboxypeptidase Y  (Saccharomyces cerevisiae) 
   S15  X-Pro dipeptidyl-peptidase (Lactococcus lactis) 
   S28  Lysosomal Pro-X carboxypeptidase (Homo sapiens) 
   S33  Prolyl aminopeptidase (Neisseria gonorrhoeae)   
S37  PS-10 peptidase (Streptomyces lividans) (Streptomyces lividans) 
 
SE  S11  D-Ala-D-Ala carboxypeptidase A (G.  stearothermophilus) 
   S12  D-Ala-D-Ala carboxypeptidase B (Streptomyces sp.) 
   S12  D-Ala-D-Ala peptidase C (Escherichia coli) 
 
 SF  S24  Repressor LexA (Escherichia coli) 
   S26  Signal peptidase I (Escherichia coli) 
   S27  Eukaryotic signal peptidase 
   S41  C-terminal processing peptidase-1 (Escherichia coli) 
   
SH  S21  Assemblin (human herpesvirus 5) 
   S23  Escherichia protease I  
   S25  Multicatalytic endopeptidase ciomplex 
   
SJ   S16  Lon-A peptidase (Escherichia coli) 
S50  Birnavirus Vp4 peptidase (infectious pancreatic necrosis virus) 
 
 SK  S14  Clp endopeptidase (subunit clp) (Escherichia coli) 
S41  C-terminal processing peptidase-1 (Escherichia coli) 
   S49  Signal peptide peptidase A (Escherichia coli) 
 
 SP  S59  Nucleoporin 145 (Homo sapiens) 
 
 SR  S60  Lactoferrin (Homo sapiens)  
 
 S-  S46  Dipeptidyl-peptidase 7 (Porphyromonas gingivalis)  
   S48  HetR endopeptidase (Anabaena variabilis) 
   S54  Rhomboid-1 (Drosophila melanogaster) 
   S62  Influenza A PA endopeptidase (influenza A virus) 
S63 EGF-like module containing mucin-like hormone receptor-like 2 
(Homo sapiens) 
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           Table 2B: Cysteine protease clans and families. 
 
 Clan  Family Example 
 
 CA  C1  Papain (Carica papaya) 
   C2  Calpain-2 (Homo sapiens) 
   C6  Potato virus Y-type helper component peptidase 
   C7  Chestnut blight fungus virus p29 peptidase 
   C8  Chestnut blight fungus virus p48 peptidase 
   C9  Sindbis virus-type nsP2 peptidase 
   C10  Streptopain (Streptococcus pyogenes) 
   C12  Ubiquitinyl hydrolase-L1 (Homo sapiens) 
   C16  Murine hepatitis coronavirus papain-like endopeptidase 1  
   C19  Ubiquitin-specific peptidase 14 (Homo sapiens) 
   C21  Tymovirus endopeptidase (turnip yellow mosaic virus) 
   C23  Carlavirus endopeptidase (apple stem pitting virus) 
   C27  Rubella virus endopeptidase 
   C28  Foot-and-mouth disease virus L-peptidase  
C31 Porcine respiratory and reproductive syndrome arterivirus-type 
Cysteine peptidase alpha (lactate-dehydrogenase-elevating virus) 
C32 Equine arteritis virus-type cysteine peptidase (porcine reproductive 
and respiratory syndrome virus) 
C33  Equine arterivirus Nsp2-type cysteine peptidase  
C36  Beet necrotic yellow vein furovirus-type papain-like endopeptidase  
C39  Bacteriocin-processing peptidase (Pediococcus acidilactici) 
C42  Beet yellows virus-type papain-like peptidase (beet yellows virus) 
C47  Staphopain A (Staphylococcus aureus) 
C51  D-alanyl-glycyl endopeptidase (Staphylococcus aureus) 
C54  ATG4 peptidase (Saccharomyces cerevisiae) 
C58  YopT peptidase (Yersinia pestis) 
C64  Cezanne deubiquitinating peptidase (Homo sapiens) 
C65  Otubain-1 (Homo sapiens) 
C66  IdeS peptidase (Streptococcus pyogenes) 
C67  CylD protein (Homo sapiens) 
C71 Pseudomurein endoisopeptidase Pei (Methanobacterium phage 
psiM2) 
C72  HopPtoN g.p. (Pseudomonas syringae) 
 
 CD  C11  Clostripain (Clostridium histolyticum) 
   C13  Legumain (Canavalia ensiformis) 
   C14  Caspase-1 (Rattus norvegicus) 
   C25  Gingipain R (Porphyromonas gingivalis) 
   C50  Separase (Saccharomyces cerevisiae) 
   
 CE  C5  Adenain (human adenovirus type 2) 
   C48  Ulp1 endopeptidase (Saccharomyces cerevisiae) 
   C55  YopJ endopeptidase (Yersinia pseudotuberculosis) 
   C57  Vaccinia virus I7L processing peptidase (vaccinia virus) 
   C63  African swine fever virus processing peptidase  
 
 CF  C15  Pyroglutamyl-peptidase I (Bacillus amyloliquefaciens) 
     
 CH  C46  Hedgehog protein (Drosophila melanogaster) 
 CL  C60  Sortase A (Staphylococcus aureus) 
 C-  C18  Hepatitis C virus endopeptidase 2 (hepatitis C virus) 
   C40  Dipeptidyl-peptidase VI (Bacillus sphaericus) 
   C53  Pestivirus Npro endopeptidase (classical swine fever virus) 
   C70  AvrRpt2 g.p. (Pseudomonas syringae) 
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   Table 2C: Metalloprotease clans and families. 
 
 Clan  Family Example 
 
 MA  M1  Aminopeptidase N (Homo sapiens) 
M2  Angiotensin-converting enzyme peptidase unit 1 (Homo sapiens) 
   M3  Thimet oligopeptidase (Rattus norvegicus) 
   M4  Thermolysin (Bacillus thermoproteolyticus) 
   M5  Mycolysin (Streptomyces cacaoi) 
   M6  Immune inhibitor A (Bacillus thuringiensis) 
   M7  Snapalysin (Streptomyces lividans) 
   M8  Leishmanolysin (Leishmania major) 
   M9  Microbial collagenase (Vibrio alginolyticus) 
   M10  Collagenase 1 (Homo sapiens) 
   M11  Gametolysin (Chlamydomonas reinhardtii) 
   M12  Astacin (Astacus astacus) 
   M13  Neprilysin (Homo sapiens) 
M26  IgA1-specific metalloendopeptidase (Streptococcus sanguinis) 
   M27  Tentoxilysin (Clostridium tetani) 
   M30  Hyicolysin (Staphylococcus hyicus) 
   M32  Carboxypeptidase Taq (Thermus aquaticus) 
   M34  Anthrax lethal factor (Bacillus anthracis) 
   M35  Deuterolysin (Aspergillus flavus) 
   M36  Fungalysin (Aspergillus fumigatus) 
   M41  FtsH endopeptidase (Escherichia coli) 
   M43  Cytophagalysin (Cytophaga sp.) 
   M57  PrtB g.p. (Myxococcus xanthus) 
   M60  Enhancin (Lymantria dispar nucleopolyhedrovirus) 
   M61  Glycyl aminopeptidase (Sphingomonas capsulata) 
   M64  IgA peptidase (Clostridium ramosum) 
   M66  StcE peptidase (Escherichia coli) 
M72  Peptidyl-Asp metalloendopeptidase (Pseudomonas aeruginosa) 
  
 MC  M14  Carboxypeptidase A1 (Homo sapiens) 
 
 MD  M15  Zinc D-Ala-D-Ala carboxypeptidase (Streptomyces albus) 
   M74  Murein endopeptidase (Escherichia coli) 
 
 ME  M16  Pitrilysin (Escherichia coli) 
   M44  Pox virus metalloendopeptidase (vaccinia virus) 
   
 MF  M17  Leucyl aminopeptidase (Bos taurus) 
 
 MG  M24  Methionyl aminopeptidase 1 (Escherichia coli) 
 
 MH  M18  Aminopeptidase I (Saccharomyces cerevisiae) 
   M20  Glutamate carboxypeptidase (Pseudomonas sp.) 
   M28  Aminopeptidase S (Streptomyces griseus) 
   M42  Glutamyl aminopeptidase (Lactococcus lactis) 
 
 MJ  M19  Membrane dipeptidase (Homo sapiens) 
   M38  Beta-aspartyl dipeptidase (Escherichia coli) 
 
MK M22  O-sialoglycoprotein endopeptidase (P.  haemolytica) 
ML  M52  HybD endopeptidase (Escherichia coli) 
 M63  Gpr peptidase (Bacillus megaterium) 
MM  M50  S2P peptidase (Homo sapiens) 
MN  M55  D-aminopeptidase DppA (Bacillus subtilis) 
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     Table 2C: (continued) 
 
 
                     Clan Family Example  
 
 MO  M23  Beta-lytic metalloendopeptidase (Achromobacter lyticus) 
  
 MP  M67  Poh1 peptidase (Saccharomyces cerevisiae) 
 
 M-  M29  Aminopeptidase T (Thermus aquaticus) 
   M48  Ste24 endopeptidase (Saccharomyces cerevisiae) 
   M49  Dipeptidyl-peptidase III (Rattus norvegicus) 
   M56  BlaR1 peptidase (Staphylococcus aureus) 
   M73  Camelysin (Bacillus cereus) 
   M75  Imelysin (Pseudomonas aeruginosa) 
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      Table 2D: Aspartic protease clans and families 
 
       
  Clan  Family Example    
   
 
  AA  A1  Pepsin A (Homo sapiens) 
    A2  HIV-1 retropepsin  
A3 Cauliflower mosaic virus-type endopeptidase  
A9 Spumapepsin (human spumaretrovirus) 
A11 Copia transposon (Drosophila melanogaster) 
 
  AB  A6  Nodavirus endopeptidase (flock house virus) 
A21 Tetravirus endopeptidase (Nudaurelia capensis omega 
virus) 
 
  AC  A8  Signal peptidase II (Escherichia coli) 
 
  AD  A22  Presenilin 1 (Homo sapiens) 
    A24  type 4 prepilin peptidase 1 (Pseudomonas aeruginosa) 
 
  AF  A26  Omptin (Escherichia coli) 
 
  A-  A5  Thermopsin (Sulfolobus acidocaldarius) 
 
 
 
 
 
 
 
      Table 2E: Threonine and unknown protease clans and families. 
 
 
 Clan  Family Example  
  
 T-  T5  Ornithine acetyltransferase precursor (S.  cerevisiae) 
 
                U-  U4  Sporulation factor SpoIIGA (Bacillus subtilis) 
  U9  Prohead peptidase (Enterobacteria phage T4) 
  U32  Collagenase (Porphyromonas gingivalis) 
  U35  Prohead peptidase (bacteriophage HK97) 
  U40  Protein P5 murein endopeptidase (bacteriophage phi-6) 
  U48  Prenyl peptidase 2 (Saccharomyces cerevisiae) 
  U49  Lit peptidase (Escherichia coli) 
  U57  YabG protein (Bacillus subtilis) 
  U61  Muramoyl-tetrapeptide carboxypeptidase (Escherichia coli) 
  U62  Microcin-processing peptidase 1 (Escherichia coli) 
 
 
 
           
 
 
 
 
 
 50
 
    Table 2F: Clans of mixed proteases. 
 
Clan  Family Example 
 
 PA  C3  Poliovirus-type picornain 3C (human poliovirus 1) 
   C4  Nuclear-inclusion-a endopeptidase (plum pox virus) 
   C24  Rabbit hemorrhagic disease virus 3C-like endopeptidase 
C30 Porcine transmissible gastroenteritis virus-type main endopeptidase 
(transmissible gastroenteritis virus) 
C37  Calicivirin (Southampton virus) 
C62  Gill-associated virus 3C-like peptidase 
S55  SpoIVB peptidase (Bacillus subtilis) 
S64  Ssy5 endopeptidase (Saccharomyces cerevisiae) 
 
 PB  C44  Amidophosphoribosyltransferase precursor (Homo sapiens) 
C45 Acyl-coenzyme A:6-aminopenicillanic acid acyl-transferase 
precursor (Penicillium chrysogenum) 
C59  Penicillin V acylase (Bacillus sphaericus) 
C69  Dipeptidase A (Lactobacillus helveticus) 
S45  Penicillin G acylase precursor (Escherichia coli) 
S58  Aminopeptidase DmpA (Ochrobactrum anthropi) 
T1  Archaean proteasome, beta component (Thermoplasma acidophilum) 
T2  Glycosylasparaginase precursor (Homo sapiens) 
T3  Gamma-glutamyltransferase 1 (Escherichia coli) 
 
PC  C26  Gamma-glutamyl hydrolase (Rattus norvegicus) 
   C56  PfpI endopeptidase (Pyrococcus furiosus) 
   S51  Dipeptidase E (Escherichia coli) 
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Table 3: Protein families of protease inhibitors. Adopted from Reeck et al., (1997). 
Sl. No. Name Approximate domain size and 
number of domains 
1.  
2.  
3. 
4. 
5. 
6.  
7. 
8. 
9. 
10. 
11.  
12. 
13.  
14. 
15. 
16. 
 
17.  
18. 
19. 
20. 
21. 
22. 
Bovine pancreatic trypsin inhibitor (Kunitz) 
Kazal serine protease inhibitor family 
Soybean trypsin inhibitor (Kunitz) family 
Bowman-Birk inhibitor family 
Potato inhibitor I family  
Potato inhibitor II family  
Squash inhibitor family 
Barley trypsin inhibitor family 
Thaumatin family 
Ascaris trypsin inhibitor family 
Locust inhibitor family 
Ecotin family 
Serpin family 
Streptomyces subtilisin inhibitor 
Hirudin family 
Cystatin family 
 
Calpastatin family 
Potato carboxypeptidase inhibitor family 
Ascaris carboxypeptidase inhibitor family 
Collagenase inhibitor family  
Ascaris pepsin inhibitor family 
α-2-macroglobulin family 
60 residues 
55 residues; up to 7 domains 
180 residues 
35 residues; 2 domains 
70 residues 
50 residues; 1 or 2 domains 
30 residues 
120 residues 
200 residues 
60 residues 
35 residues 
140 residues; 2 subunits 
400 residues 
110 residues 
65 residues 
110 residues; usually single domain but 3 
inhibitory domains in kininogens and 8 in 
potato mutlistatin 
140 residues; 4 domains 
40 residues 
40 residues 
200 residues 
150 residues 
1500 residues; 2 or 4 subunits 
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    Table 4: Proteases in humans and model species. Adopted from López-Otín and Overall, (2002).
 
                    Catalytic class of protease 
        Species            Total     Aspartic     Cysteine      Metallo      Serine    Threonine 
 
      Homo sapiens  461       18  121         159   140       23 
 
      Caenorhabditis elegans 353       26   93         151             62           21 
 
      Drosophila melanogaster 513       38   59         157    225         34 
       
      Mus musculus  383            11               93                120            137         22 
 
      Rattus norvegicus  227            10               41                 77              80          19 
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       Table 5: Inhibitors studied/identified from different insect species. 
 
 Inhibitor class    Insect species 
 
Serine protease inhibitors Acanthocephala femorata, Acheta domesticus,  
Aedes aegypti, Antheraea mylitta, Antheraea perni,  
Apis mellifera, Bombyx mori, Dactylopius coccus,  
Dipetalogaster maximus, Drosophila melanogaster,  
Drosophila virilis, Haematobia irritans, Hemileuca oliviae,  
Leucophaea maderae, Locusta migratoria, Manduca sexta,  
Mythimna unipuncta, Nauphoeta cinerea, Philosamia cynthia 
 ricini, Rhodnius prolixus, Schistocerca gregaria,  
Sarcophaga bullata, Tenebrionidae spp., Traitoma infestin,  
Trichoplusia ni  
 
Cysteine protease inhibitors Bombax mori, Drosophila melanogaster,  
Sarcophaga crassipalpis, Spodoptera littoralis,  
Trichoplusia ni 
 
Metallo protease inhibitors Drosophila melanogaster, Galleria melonella 
 
Aspartic protease inhibitors - 
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2. Research objectives 
Under normal physiological condition proteolytic processes in an organism are 
precisely regulated in various ways. One way to control proteolysis is through protease 
inhibitors. Precise levels of protease inhibitors are to regulate proteases. Because of their 
importance in regulating proteolysis, protease inhibitors are of importance in various 
areas such as medicine and agriculture. In medicine protease inhibitors are used as drugs 
against the HIV proteases. In agriculture, many plant protease inhibitors are identified 
from various plant species that inhibit insect digestive proteases.  These molecules serve 
as attractive candidates in developing transgenic crops to control insect pests. The 
specific objectives of my research were: 
(1) To identify cDNAs that encode protease-inhibitor-like proteins. 
(2) To determine whether the cDNA encoded proteins possess inhibitor activity to             
specific proteases. 
(3) To determine the expression profile of different genes at different 
developmental stages and in different tissues.  
(4) To determine the tissue localization of protease inhibitor like proteins. 
(5) To determine how the genes are organized in the Hessian fly genome.  
Successful completion of the above objectives will provide important information on 
composition, specificity, function and genomic organization and expression regulation of 
protease inhibitor in the Hessian fly. These results will provide a foundation for future 
studies to understand the proteolysis and its regulation in this insect. 
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 3. Materials and methods 
3.1 Hessian flies 
Hessian flies originally collected from Ellis county (Gagane and Hatchett, 1989) 
were maintained on susceptible wheat seedlings (‘Newton’ or ‘Karl92’) in an 
environmental chamber at 20oC and 12:12 (L:D) photoperiod. The biotype colony that 
was maintained consisted of the Great Plains.  
 
3.2 cDNA library construction 
The cDNA library was constructed as described previously using a 'SMART ' 
cDNA library construction kit from Clontech (Palo Alto, CA, USA) (Zhu et al., 2004). 
Briefly, three hundred midguts or two hundred pairs of salivary glands were obtained by 
dissecting 3-day-old larvae and immediately placed them into TRI reagent  (Molecular 
Research Center, Inc.). Total RNA was then isolated from the respective tissues. The 
cDNA libraries were constructed following the protocol provided by Clontech (Palo Alto, 
CA, USA) with one modification. The PCR fragments were cloned directly into a 
plasmid using a TOPO TA cloning kit (Invitrogen, Carlsbad, CA, USA). Individual 
cDNA clones were selected and arrayed into 96 well plates. Plasmid DNA was isolated 
from the plates using a Qiagen BioRobot 3000 and sequenced in an ABI 3700 DNA 
analyzer. 
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 3.3 Sequence analysis 
Open-reading-frame (ORF) and sequence-similarity analysis were performed 
using the National Center for Biotechnology Information (Bethesda, MD) website 
(http://www.ncbi.nlm.nih.gov). The pI prediction of mature proteins was performed using 
‘Compute pI/Mw tool’ (http://us.expasy.org/tools/pi_tool.html). The amino acid 
sequences of proteins were deduced from the cDNA through ExPASY proteomics tools 
available on the website of the Swiss Institute of Bioinformatics  
(http://www.expasy.ch/tools/). The BCM search launcher program 
(http://searchlauncher.bcm.tmc.edu/) was used to conduct ClustalW multiple-sequence 
alignment. The shading of conserved residues amino acid was boxed using the program 
available at (http://www.ch.embnet.org/software/BOX_form.html).  
 
3.4 Phylogenetic analysis 
 The cDNA encoded protein sequences were used to construct the phylogenetic 
tree with the software package GeneBee, available at 
(http://www.genebee.msu.su/services/phtree_reduced.html). The boot strap values were 
obtained using the software package Phylipv4.0. The boot strap values obtained from the 
Phylip program were placed at respective branch points of the phylogenetic tree obtained 
from GeneBee.  
 
3.5 BAC library construction 
A BAC DNA library was constructed in our lab in collaboration with Amplicon, 
(Pullman, WA), a commercial research company. The inserts were ligated into the Hind 
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 III site of pECBA1 vector with average size around 150 kb. The BAC clones were 
spotted on nylon membranes. Each membrane contained 384 grids and each grid was 
spotted with 8 BAC clones in duplicates. Totally each filter was spotted with 6144 BAC 
clones.  
 
3.6 Probe preparation 
To generate cDNA probes, cDNA clones were inoculated into 5ml of terrific 
broth containing 50µg/ml of ampicillin and were grown overnight at 37oC. Plasmid DNA 
was isolated from the culture according to Maniatis et al. (1982). The insert from 
individual clones were amplified through PCR amplification. PCR reactions were carried 
out in buffer containing 50ng of plasmid DNA, 0.25 mM dNTP’s, 2.5 mM MgCl2, 10 pm 
of each forward (5PCR 5’-AAGCAGTGGTATCAACGCAGAGT-3’) and reverse 
(CDCIII/3PCR 5’-ATTCTAGAGGCCGAGGCGGCCGA-3’), 5 units of Taq 
Polymerase, 2µl of 10x PCR buffer) with 40 cycles of 94oC for 1 min, 55oC for 2 min, 
72oC for 2 min. The PCR products were separated on 1.2% agarose gel. DNA bands with 
appropriate size were excised from the agarose gel and purified using Geneclean Turbo 
PCR purification kit from Q Biogene Inc., (Carlsbad, CA). 
Purified DNA fragments were radio-labeled using Prime-It® II Random primer 
labeling kit from Stratagene, (La Jolla, CA). Specifically 50ng of cDNA, 5µl of random 
9-mer primers (27OD units/ml), in 35µl of water were boiled for 5 min. The boiled 
solution was put on ice for 2 min. To each tube 10µl of 5x dCTP buffer (contained 
0.1mM of each dCTP, dATP, dTTP, dGTP), 5µl of 32P (1mC) and 2µl of Klenow enzyme 
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 (2 units/µl) was added and kept at 37oC for 1 hour. Unincorporated radioactive isotope 
was removed from the solution by passing through NucTrap® probe purification columns 
from Stratagene, (La Jolla, CA). The purified probes were used for hybridization. 
 
3.7 BAC library screening 
BAC membranes were washed in 500 ml of solution containing 50 mM Tris, pH 
8.0, 1 M NaCl, 1 mM EDTA, and 0.1% SDS for one hour at room temperature for three 
times. The membranes were then prehybridized in a polythene bag containing 15ml of 
prehybridization buffer (10% dextran sulfate/1% SDS/ 1M NaCl, pH8.0) at 42oC for one 
hour. Hybridization was carried out overnight at 42°C in the same plastic bag by adding 
the labeled probe. The membranes were then washed twice with 2x SSC at room 
temperature for 30 min, twice with 2x SSC plus 1% SDS at 65 °C for 30 min, and twice 
with 0.1× SSC plus 1% SDS at room temperature for 30 min. After washing, the 
membranes were exposed to Kodak SR-5 X-ray film for 1 hour to overnight depending 
upon the signal. The X- ray films were developed by transferring the film first to GBX 
developer and then to fixer, obtained from Kodak Company, Rochenster, NY, for 1 and 4 
min, respectively. Positive colonies were identified according to the positions of the 
arrays.  
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 3.8 BAC DNA isolation and Southern blot 
BAC DNA from positive clones was isolated as described by Maniatis et al., 
(1982) with a modification. Briefly, individual BAC clones were grown in 5 ml Terrific 
Broth (TB) medium containing 4x (15µg/ml) of chloromphenicol for 2 hours at 37oC. To 
increase the yield of BAC DNA, another 15µg/ml of chloramphenicol was added to the 
culture after two hours incubation. The culture was allowed to grow overnight and BAC 
DNA was then isolated.  
For Southern blot analysis, BAC DNA was completely digested with EcoR I, 
BamH I, and Hind III (~5-10µg of BAC DNA, 1x buffer, 30 units of enzyme and 0.25mg 
of BSA) at 37oC overnight. DNA fragments were separated on 1% agarose gel and were 
transferred onto the GeneScreen Plus® hybridization membrane obtained from 
PerkinElmer Life Sciences, Inc. (Boston, MA). The membrane was baked at 80oC for 2 
hours for cross linking. The prehybridization, hybridization, washing, exposing and 
developing conditions were same as mentioned in BAC library screening. The 
membranes were hybridized with 11A6 and 14A4 cDNA probes, respectively. 
 
3.9 RNA extraction and Northern analyses 
Total RNA was extracted from the different stages of Hessian fly larvae (0 day, 2 
day, 4 day, 6 day, 12 day larvae, pupa and adult) using TRI reagentTM following the 
protocol from Molecular Research Center, Inc., (Cincinnati, OH) with few changes. 
100mg of larval tissue were homogenized in 1ml of TRI reagent using a tissue 
homogenizer. The homogenate was stored for 5 minutes at room temperature for 
dissociation of nucleoprotein complexes. To the homogenate, 02.ml of chloroform was 
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 added, mixed and kept at room temperature for 10 minutes. The homogenate was 
centrifuged at 10,000xg for 10 minutes. The supernatant (0.5 ml) was transferred to a 
new eppendorf tube and the RNA was precipitated using an equal amount of isopropanol. 
The samples were stored at room temperature for 10 minutes and centrifuged at 10,000xg 
for 10 min at 4oC.  The RNA pellet was washed with 1ml 75% DEPC treated ethanol and 
centrifuged at 10,000xg for 5min at 4oC. The 75% ethanol was removed and the pellet 
was air dried. The RNA pellet was dissolved in an appropriate amount of DEPC treated 
water. 5µg of total RNA was separated on 1.2% agarose gel containing formaldehyde and 
MOPS buffer. The RNA separated on the gel was blotted on the GeneScreen Plus® 
membrane. The RNA was cross linked onto the membrane by baking the membrane at 
80oC for two hours. The prehybridization, hybridization, washing, exposing and 
developing conditions were same as mentioned in Southern analysis. 
 
3.10 Real-Time PCR 
The first instar Hessian fly larvae were dissected in 1x PBS saline. The salivary 
glands, midgut, malpighian tubules (Fig. 1), fatbody, and carcass were collected and were 
immediately put into TRI reagent  (Molecular Research Center, Inc.) separately. Total 
RNA was isolated from all the tissues as well as from whole larvae. The cDNA was 
obtained from the total RNA through reverse transcription. For reverse transcription, 1 µg 
of total RNA, 0.1 nM (0.1 nm/µl) poly (T) was heat denatured at 72oC for 2 minutes in 15 
µl of DEPC water. Then the solution was cooled on ice for 1 minute. After cooling,  3µl 
of first strand buffer, 1µl of 10mM dNTP and 1µl of superscript reverse transcriptase 
(from BD Biosciences), was added to the solution. After cDNA synthesis, the RNA in the 
  61 
  
 
 reaction mixture was removed by adding 1µl of 10units/µl DNase free RNase (Promega 
Corporation) and keeping the tubes at 37oC for 1 hr. 
The cDNA mixture from all the tissues was diluted to get 1.25ng/µl. The diluted 
samples were used for normalization of RPS30 transcripts using a pair of primers (Table 
1) for the RPS30 gene. The normalized samples were used for transcript quantification. 
For the real-time PCR analysis, 5µl of normalized transcript quantification was used as 
template. The PCR products were labeled with SYBR green dye, (Biorad, Hercules), 
during amplification. The real-time amplification protocol to amplify 11A6, Lg2A3, and 
11C4 consisted of 95oC for 5 minutes, then 45 cycles of 95oC for 20 sec, 62oC for 45 sec, 
followed by 95oC for 1 min and 55oC for 10 sec for 80 cycles. The annealing and 
extension for 14A4 and LG2F7 were 63oC and 64.5oC, respectively. 
To make standard curves of different cDNAs, the recombinant pCR® 2.1-TOPO 
plasmid containing different cDNAs were isolated using Qiagen isolation kit (Qiagen 
Inc., Valencia, CA). The concentration was measured using Nanodrop. The plasmids 
were diluted and real-time PCR reaction was conducted with the DNA concentration 
ranging from 1 ng to 1 fg to derive the standard curve with the above PCR conditions. 
The copy number of plasmids ranged from 211303557 (1ng) to 211.303557 (1fg) for 
11A6, 206333957.3 (1ng) to 206.3339573(1fg) for 14A4, 206848505.8 (1ng) to 
206.8485058 (1fg) for Lg2A3, 204392643.2 (1ng) to 204.3926432 (1fg) for Lg2F7 and 
207837986.1 (1ng) to 207.8379 for 11C4.  
Ct value is the cycle number at which the fluorescence crosses the threshold line 
(default set for different genes) which is available during the reaction. The Ct values for 
each gene with different PCR DNA concentrations were used to establish a standard 
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 curve against the copy number in log scale. The regression equation obtained from the 
curve for different cDNAs by plotting a regression line was used to determine the log 
copy number of different cDNAs in different tissues. The log copy number was converted 
to exponential numbers and plotted on the graph.   
The real time PCR primers were designed using the software, Beacon designer 
version 2.0 from Biosoft International, Palo Alto, CA.  The primer pairs specific to each 
gene (Table. primer sequences) were synthesized by IDT Inc., Caraville, IA and 
Invitrogen, Carlsbad, CA. The specificity of the primer pairs to each gene was tested 
experimentally using genomic DNA and cDNA from the reverse transcription. As a 
control, a primer pair of the ribosomal protein S30 was synthesized according to its 
cDNA sequence. The real-time PCR products from this ribosomal protein mRNA were 
used as an internal control for normalization of transcripts in different tissues.      
      
3.11 Preparation of expression constructs 
The vector used to construct the expression system was pCR® T7/NT-TOPO, 
from Invitrogen, Carlsbad, CA (Fig. 2).  This vector contains the T7 promoter priming 
site, a region coding for polyhistidine (6xHis) and Xpress epitope, a enterokinase 
recognition site, cloning site, a T7 reverse priming site, and a T7 transcription termination 
region. It also contains f1 and pUC origin and ampicillin selectable marker genes. The 
length of 6x polyhistidine, Xpress epitope tag and enterokinase region together account 
for 35 amino acid residues.  
The 11A6 and 14A4 open reading frame cDNA inserts were prepared through 
PCR (100ng DNA, 2.5mM of MgCl2, 0.2mM dNTP’s, 10 pM of each forward and 
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 reverse primer and 8 units of Taq polymerase) from the cDNA library using forward(D3) 
(5’-ATTGCGGCACCGTTGGCGGAA-3’ and 5’-AATGAAGACAACAAACCAAA-
3’), and reverse(U3) (5’-AATGAAACTATCGCCACATAA-3’ and 5’-
TGTTAAAGATTTGGATACAG-3’) primers specific for the 11A6 and 14A4 cDNAs 
respectively. The prepared insert were ligated into the pCR® T7/NT-TOPO (Invitrogen, 
Carlsbad, CA, USA) expression vector containing the T7 promoter priming site, a region 
coding for polyhistidine (6xHis) and ampicillin and zeocin selectable marker genes. The 
ligation reaction consisted of 1µg of insert, 1µl of TOPO cloning mixture (Invitrogen, 
Carlsbad, CA, USA), 1µl salt solution (1.2M NaCl, 0.06M MgCl2) and the reaction 
volume was made up to 6µl. The reaction was allowed for 20 minutes at room 
temperature.  
Two microliter of ligation mixture was transformed on to TOPO-10 chemically 
competent cells supplied by Invitrogen, Carlsbad, CA, USA. Initially, the competent cells 
were thawed on ice for 5 minutes. The ligation mixture was mixed with competent cells 
and allowed to stand on ice for 30 minutes. Afterwards, the competent cells were heat 
shocked at 42oC for 30 seconds and immediately kept on ice for 2 minutes. The 
transformed was plated onto the ampicillin (50µg/ml) plates. The plates were incubated at 
37oC overnight.  
Positive clones from 11A6 and 14A4 were inoculated into 5 ml LB medium 
containing 1x ampicillin (50µg/ml), grown overnight, and plasmids were isolated as per 
the protocol described by Maniatis et al., (1982). The orientations of the ligated cDNAs 
inserts were determined through PCR using T7 primer (5’-
TAATACGACTCACTATAGGG-3’) and U3 upstream primer specific for the 11A6 and 
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 14A4 cDNAs (100ng DNA, 2.5mM of MgCl2, 0.2mM dNTP’s, 10 pM of each forward 
and reverse primer and 8 units of Taq polymerase). The PCR products were separated on 
the gel and observed for the correct product size. The clones with appropriate product 
size and with right orientation were selected to transform into expression cells. 
 
3.12 Protein expression  
The expression constructs containing the 11A6 and 14A4 cDNA inserts were 
transformed into Rosetta Blue BL21-DE3 competent cells, Novagen®. A single colony 
of each 11A6 and 14A4 cDNA expression clones was inoculated into 5 ml LB medium 
containing 1x ampicillin (50µg/ml) and 1x chloromphenicol (34µg/ml) and allowed to 
grow over night at 37oC. To a fresh 5 ml of LB, 50 µl of the overnight bacterial culture 
was inoculated and grown at 37oC for 3 hours. The 5ml overnight grown culture was 
divided equally into two tubes. For one tube 10mM IPTG was added, and the tubes 
containing the culture with and without IPTG were grown for 3 hrs at 37oC. The culture 
was centrifuged at 5000 xg for 10 minutes at 4oC. The pellet was vortexed with 135 µl of 
TE buffer (10mM Tris, 1mM EDTA). Fifteen µl of 10x SDS sample buffer (10% 
glycerol, 2% SDS, 0.1% bromophenol blue, 0.5M Tris pH 6.8) was added, mixed and the 
samples were boiled for 10 minutes. The samples were stored on ice for 2 minutes and 
centrifuged at 8,000xg. The soluble fraction (supernatant) was separated on a 13% SDS-
PAGE. 
For large scale protein expression, 50 ml of overnight culture of each 11A6 and 
14A4 was inoculated into 500 ml of LB medium separately and allowed to grow for 3 hrs 
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 at 37oC. The culture was grown for 4 hrs at 37oC by adding 10 mM IPTG to induce 
protein. 
 
3.13 Protein purification  
Native protein of 11A6 and 14A4 were purified from the IPTG induced culture 
using the ProBondTM Purification System (Invitrogen, Carlsbad, CA).  Bacterial culture 
(250 ml) pellet of cDNA clones 11A6 and 14A4 were resuspended separately in 25ml of 
native purification buffer, pH 8.0 (25mM Tris, 0.25M NaCl) with 0.1% triton X-100. 
Lysozyme (8mg/50ml of culture pellet) was added to the suspension and stored on ice for 
1 hour. The solution was sonicated on ice for 5 minutes with 10 second bursts. The lysate 
was centrifuged at 8000xg for 15 min to pellet the debris. The supernatant was collected 
and used for purification of protein. 
The nickel resin was packed into the column by pipetting 2 ml of resin into a 
10ml purification column and allowed to settle by gravity. The supernatant was removed 
from the column, and the resin was washed by resuspending in 8 ml of sterile water by 
inverting the column. The resin was allowed to settle down by gravity. Again the 
supernatant was removed from the column by pipetting. After two washes with water, the 
resin was resuspended into 1x native binding buffer, pH 8.0 (25mM NaPO4, 0.25M 
NaCl) and allowed to settle. The supernatant was removed, and this step was repeated 
one more time. The column was used immediately to purify the His-tagged protein.  
The native binding buffer was removed from the column, and 8ml of prepared 
protein lysate was applied onto the column. His-tagged fusion proteins were allowed to 
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 interact and bind to the nickel resin for 1 hour at room temperature by gently inverting 
the column. The column material was allowed to settle by gravity, and the supernatant 
was removed. The column was washed twice with 1x native wash buffer, pH 8.0, and 
eluted with 6ml of native elution buffer. One ml fractions were collected and separated 
on the 13% SDS-PAGE. Fractions containing the protein were pooled. The pooled 
fractions were filtered in a macrosep® 3K centifugal devices supplied by PALL Life 
Sciences (Ann Arbor, Michigan) to concentrate and remove salts.  
 
3.14 N-terminal His-tag cleavage 
To remove the N-terminal His-tag from the fusion protein, in a reaction volume of 
150µl, 4.2µg of 11A6 and 14A4 recombinant fusion proteins were taken separately. 
Fifteen µl of enterokinase buffer and 15 units of enterokinasemaxTM, Invitrogen 
(Carsbald, CA), were added and incubated at 37oC overnight. The mixture was separated 
on 13% SDS-PAGE. The reaction was scaled up and the mixture was passed through a 
nickel resin column to obtain mature protein.  
 
3.15 Protein determination 
 Protein concentration was determined by the bicinchoninic acid method (Smith et 
al., 1985). 
 
 
 
  67 
  
 
 3.16 Inhibition assay  
3.15.1 Assay with commercial enzymes 
Five grams of first instar Mayetiola destructor larvae were collected and ground 
in 250µl of extraction buffer (50 mM Tris-HCl, pH 8.0, 0.1% TrtionX-100). The extract 
was centrifuged three times at 10,000xg, 15 minutes each at 4oC to remove the debris. 
The protease extract was aliquoted into eppendorf tubes and frozen at -20oC. Commercial 
enzymes trypsin, chymotrypsin and papain were purchased from Worthington 
Biochemical Corporation, Lakewood, NJ. The enzymes trypsin and chymotrypsin were 
dissolved in 0.001N HCl at 1mg/ml and 10mg/ml, respectively. Papain was dissolved in 
cysteine HCl buffer, (50 mM cysteine-HCl pH 6.2, 10 mM EDTA and 60 mM 
mercaptoethanol). 
Inhibition assay were conducted by measuring the hydrolysis of casein conjugated 
to a fluorescent probe, BODIPY-TR-X (Molecular Probes, Eugene, OR) according to a 
method previously described (Oppert et al., 1997). The starting concentration of 
recombinant 11A6 and 14A4 inhibitors were 1.3µM and 2.56µM, respectively. The 
assays were carried out in 100µl. In the assay for trypsin, chymotrypsin and Hessian fly 
larval extract, a universal buffer, pH 7.8 was used. For papain, yellow mealworm and red 
flour beetle gut extracts, a universal buffer, pH 6.2 was used. Inhibitors were 
preincubated with trypsin, chymotrypsin, papain, and with gut extracts of Hessian fly, 
yellow mealworm and red flour beetle ( 0.5 gut equivalents) for 10 min at 37°C before 
the addition of substrate. At time 0, 10 µl of a stock solution of 10 µg/ml of fluorescent-
labeled casein, BODIPY-TR-X, was added to each well to initiate the reaction. The plates 
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 were incubated at 37°C for 4 hr and inhibitory activity was measured using a 
fluorescence microplate reader (Fluoroskan Ascent FL, Labsystems, Thermo Electron 
Corp., Milford, MA), with an excitation coefficient of 584 nm and emission of 620 nm. 
The percentage inhibition was calculated by dividing the value obtained from incubations 
with inhibitor by control incubations without inhibitor, and multiplied by 100. IC50 values 
were the amount of the inhibitor concentration resulting in 50% inhibition and were 
calculated using linear regression. IC50 of 11A6 and 14A4 towards trypsin and 
chymotrypsin were calculated. The residual enzyme activity was plotted against the 
inhibitor to enzyme molar ratios.  
3.17 Protein sample preparation for Western analysis 
The first instar Hessian fly larvae were dissected in 1x PBS, pH 7.4, (137mM 
NaCl, 2.7mM KCl, 8mM Na2HPO4, 2mM KH2PO4). Salivary gland pairs (125) and 
malpighian tubules (125) were collected separately in 50 µl extraction buffer (50mM 
Tris-HCl buffer, pH 8.0). The tissue was homogenized through pipetting action. The 
extract was centrifuged at 8000 xg and the supernatant was collected.  
To prepare midgut and midgut extract, intact 100 midguts were collected from the 
dissected insects, placed on a slide and punctured with a needle. The released midgut 
contents, called midgut extract, were collected and subjected to electrophoresis. The 
midgut without gut contents were collected in 200 µl of extraction buffer and the total 
proteins were extracted as mentioned above. 
Hemolymph was prepared from 6 day old insects. The insect cuticle was pricked 
with a needle and the hemolymph was collected in 1:1 anticoagulant solution (40mM 
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 sodium citrate buffer, pH4.5, 150mM NaCl, 15mM EDTA and 2mM 
phenylmethylsulfonyl fluoride. The contents were centrifuged at 8000xg and supernatant 
was collected.  
 
3.18 Antibody preparation 
 Antibody against the 14A4 peptide, (KDYYDHSSQNECKLPATFAK), derived 
from 14A4 was produced commercially by Bethyl Laboratories Inc., (Montgomery, TX). 
The 14A4 peptide was conjugated to KLH carrier and injected into rabbits. The 
immunosorbents were prepared by conjugating the peptide with agarose. Antibodies were 
affinity purified by passing hyperimmune serum from rabbits against immunosorbents.  
 
3.19 Western blot 
About 2 µg of protein from salivary gland, malpighian tubule, midgut and midgut 
extract along with purified recombinant protein 14A4 were separated on 13% SDS-
PAGE (Laemmli, 1970). The protein samples were then blotted on to the HybondTM-P 
filter membrane (Amersham Pharmacia Biotech). The membrane was blocked with 5% 
milk in 1x PBS containing 0.1% TritonX-100 (PBST) for 1 hour at room temperature. 
The membrane was washed with 1x PBST 3 times for 15 minutes each at room 
temperature. Then the membrane was incubated with 2.5% milk containing 14A4 
primary antibody (1: 1000) for 1 hour at room temperature. The membrane was washed 
with 1x PBST with several changes of buffer up to 4 hours. The blot was then incubated 
in 2.5% milk containing an anti rabbit secondary antibody (1:1000) for 1 hour at room 
temperature. The membrane was washed with 1x PBST up to 4 hrs with several changes 
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 of buffer. The membrane was placed on filter paper and activated by placing it in a 
substrate solution containing equal volume of ECL solution A and B, (Amersham 
Pharmacia Biotech Inc.) for 5 minutes. The excess solution was removed and the 
membrane was covered with saran wrap. The filter was exposed to Kodak SR-5 X-ray 
film for 10 min and the film was developed as described previously. 
 
3.20 Immunohistochemistry 
 Salivary glands, midgut, and malpighian tubules were collected by dissecting first 
instar Hessian fly larvae in 1x PBS. The tissues were immediately fixed in 4% 
paraformaldehyde overnight at 4oC. The tissues were washed six times, 15 minutes each 
with 1x PBS containing 1% TritonX-100 (1x PBST). Then the tissues were incubated 
overnight at 4oC in 1:1000 primary antibody diluted in 1x PBST. The tissues were 
washed eight times, 15 minutes each with 1x PBST. Then the tissues were blocked 
overnight at 4oC with 5% goat serum. The tissues were then washed with 1x PBST six 
times, 15 minutes each. The tissues were then incubated with 1:500 secondary antibody 
in 1x PBST overnight at 4oC and the samples were covered with aluminum foil to avoid 
light. The samples were removed and washed eight times in 1x PBST. Tissues were 
nuclei stained with DAPI (4'-6-Diamidino-2-phenylindole), 1:1000 in 1x PBST and 
washed four times. Tissues were mounted on a glass slide using mounting medium and 
the tissues were excited at 550nm under a confocal microscope (Leica Microsystems).  
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Figure 1: Alimentary canal of Hessian fly larva showing salivary gland (SG), foregut 
(FG), midgut (MG), hindgut (HG) and malpighian tubule (MT). Figure adopted from 
Grover et al., (1988).  
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Figure 2: Expression construct used to clone the 11A6 and 14A4 cDNA inserts. The 
construct contains pUC origin and f1 ori sites, T7 polymerase priming site, RBS-
ribosomal binding site, ATG-start codon, 6xHis-region coding for 6 histidine residues, 
region coding for Xpress epitope, EK-region coding for enterokinase cleavage site, 
multiple cloning site and T7 termination region and ampicillian marker gene. 
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Table 1: Primer sequence of different protease inhibitor genes used in real-time                  
PCR. 
      
Clone Name Primer Type Sequence Product Size 
F 5’-GCTGCGTTGACAGTATTTTGG-3’ 11A6 
R 5’-TCGCTACCGTCACAGTATTTG-3’ 
146 
F 5’-TACGAGGACTATTGCTGGACTC-3’  14A4 
R 5’-CAGGGCGACTCCAATTATAACC-3’ 
100 
F 5'-TCTGCTCGTCTTCGTTACATC-3'  Lg2A3 
R 5'-TTGCACAAGTGTCTCTAGCG-3' 
125 
F 5’-GACTATTGCTGGACTCTGAACG-3’  Lg2F7 
R 5’-ACCGAGCAGAGCGATTCC-3’ 
110 
F 5’-CACCGAAAGACTGTGGACC-3’ 11C4 
R 5’-GATTTGACGTTGATCTGGACAC-3’ 
110 
F 5’-ACAAAATTGCCACTTTGGAAGG-3’ RPS30  
R 5’-TCAAAGCTGCTCAATTCGTTAG-3’ 
105 
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4. Results 
 
A Hessian fly database containing more than 8000 ESTs had been established 
previously. Two thousand ESTs were obtained by random sequencing a cDNA library 
made from dissected guts (Zhu et. al., 2005). The other six thousand ESTs were derived 
from cDNA libraries made from dissected salivary glands (Chen et. al., 2003). Analysis 
of the EST database using GAP3 and other analytic tools revealed that there are several 
groups of genes that encode proteins with structural similarities to protease inhibitors. 
The sequences of the putative proteins among different groups are highly diversified. 
However, the number and positions of cysteine residues in the proteins are highly 
conserved. The purpose of this research was to determine the function of these diversified 
proteins and the genomic organization and expression regulation of the corresponding 
genes. 
 
 4.1 cDNAs encoding diversified proteins with conserved cysteine 
residues 
Full length cDNA that encode proteins with conserved cysteine residues 
according to EST prediction were sequenced and characterized. Phylogenetic analysis of 
29 unique proteins encoded by the cDNAs sorted the proteins into three lineages and five 
groups (Fig. 1). Lineage I and III each represent an independent group. Lineage II was 
further separated into three sublineages, each of which represents a different group. 
Sequence analysis revealed that members from the same group share greater than 85% 
sequence identity with E-value < 10-50 while members from different groups share less 
than 35% identity with E-value >100.  
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  4.1.1 Group I. The complete nucleotide and predicted amino acid sequences of a 
representative cDNA clone (11A6) from Group I are shown in the Fig. 2A. The cDNA 
contains 418 nucelotides and encodes a protein of 101 amino acids. The first 23 amino 
acids were predicted to consist of secretion signal peptides. This cDNA encodes a mature 
protein with Mr 9 kDa and pI 5.63.  
Sequence alignment of the putative proteins deduced from ten cDNAs in this 
group is shown in Fig. 2B.  The ten cDNAs encode very similar proteins with only a few 
amino acid substitutions. All the members contained 10 cysteine residues except 11A6 
where only 9 cysteine residues were present. The cysteine residue at position 46 of 11A6 
was substituted by an arginine residue. The cysteine residues were located at positions 
Cys36, Cys46, Cys50, Cys55, Cys64, Cys68, Cys74, Cys76, Cys88, and Cys94. The position of 
cysteine residues are completely conserved among different members of this group. The 
P1 reactive site is at the 52nd position. The putative P1 site residue for group 1 proteins is 
aspartic acid. Nucleotide sequence alignment of the ten cDNAs is shown in Fig. 2C. All 
the cDNAs contain a 5’ inframe stop codon, start codon, stop codon and poly (A) signal 
at 3’ end. The nucleotide identity between members varied from 95%-97% (data not 
shown).  
4.1.2 Group II. The nucleotide and predicted amino acid sequences of a 
representative cDNA clone (14A4) are shown in Fig. 3A. The cDNA contains 500 
nucleotides and encodes a mature protein with Mr 9.57 kDa and pI 7.67.  
There are nine members in this group. The amino acid alignment for these 
members is shown in Fig. 3B. The predicted signal peptide is 21 amino acids except 
S17B2, which was predicted to have 27 amino acids for the secretion signal peptide. 
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Most of the members are very similar with only a few amino acid substitutions, except 
S17B2 and Sg6G2, which have substantial amino acid substitutions, an insertion/deletion, 
and different endings. The number and position of cysteine residues are completely 
conserved in all members. The cysteine residues are located at positions Cys36, Cys37, 
Cys50, Cys55, Cys67, Cys79, Cys81, Cys93, and Cys99. P1 reactive site residue is lysine at the 
52nd position except in Sg6G2, in which P1 residue is an isoleucine. Figure 3C shows the 
nucleotide sequence alignment of nine cDNAs of this group. More nucleotide variations 
are observed in cDNA clones S17B2 and Sg6G2. The cDNAs contain a 5’ inframe stop 
codon, start codon, stop codon, and poly (A) signal at 3’ end. The nucleotide identity 
between members ranged between 83%-97% (data not shown). 
4.1.3 Group III. The nucleotide and deduced amino acid sequences of a 
representative member (LG2A3) in group III is shown in Fig. 4A. The cDNA contains 
423 nucleotides and encodes a protein with 96 amino acids. The predicted signal peptide 
is 21 amino acids. Therefore, the cDNA can encodes a mature protein of 75 amino acids 
with predicted Mr 8.47 kDa and pI 4.80.  
There are seven members in this group. Alignment of the amino acid sequences of 
the members is shown in Fig. 4B. The predicted signal peptide contains 21 residues, 
except for clone Lg2G5, which has a predicted signal peptide of 24 residues. The 
increased length in the signal peptide of Lg2G5 is due to an insertion/deletion in this 
protein. Members in this group are very similar with only a few amino acid substitutions 
and a small insertion/deletion in one member. All the members contain 8 cysteine 
residues, except Pg10A8, which contains an arginine instead of cysteine at position 73. 
The position of the cysteine residues are at Cys33, Cys46, Cys51, Cys63, Cys73, Cys75, 
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Cys87, and Cys93. The predicted P1 site residue is lysine at the 48th position in the 
sequence alignment. The nucleotide sequence alignment is shown in Fig. 4C. The Sg6C8 
contains an addition segment in the cDNA. The identity between members varied from 
94%-99% (data not shown).  
4.1.4 Group IV. The nucleotide and predicted amino acid sequences of a 
representative clone (LG2F7) in this group is shown in Fig. 5A. The cDNA contains 535 
nucleotides and encodes a protein with 103 amino acids. The first 21 amino acid residues 
are predicted to constitute a secretion signal peptide. Thus, this cDNA encodes a mature 
protein of 82 amino acids with a predicted Mr 9.53 kDa and pI 4.64. There is another 
member that belongs to this group. The two members share 90% amino acid sequence 
identity (Fig. 5B). Both proteins contain 10 cysteines in the mature protein. In addition, 
there is an extra cysteine residue in LG2F7 in the signal peptide region. The cysteine 
residues are located at positions Cys2, Cys23, Cys32, Cys33, Cys46, Cys51, Cys63, Cys75, 
Cys77, Cys89, and Cys95. Arginine is the predicted P1 site residue located at the 53rd 
position of the protein. Figure 5C shows the nucleotide alignment between LG2F7 and 
Pg7F5. Both cDNAs contain addition and deletion of nucleotides at the 5’ end. The 
nucleotide identity between the two members is 92% (data not shown). 
4.1.5 Group V. There is only one member in group 5. The cDNA and deduced 
amino acid sequences are shown in Fig. 6. The cDNA contains 447 nucleotides and 
encodes a protein of 118 amino acids. The first 26 residues are predicted to constitute a 
secretion signal peptide. Therefore, this cDNA encodes a mature protein of 92 amino 
acids with a predicted Mr 10.25 kDa and pI 6.78. The protein contains 9 cysteine residues 
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which are located at Cys32, Cys40, Cys54, Cys59, Cys66, Cys82, Cys84, Cys96, and Cys104. 
The reactive site at P1 site tyrosine is located at the 56th position. 
 
4.2 Structural similarity between groups and with known protease 
inhibitors 
 The common feature in the protein structure among different groups is that all 
members contain similar numbers (7 to 10) of cysteine residues in the mature proteins. 
Pair-wise comparison between individual groups demonstrated that the positions for 
many of the cysteine residues are highly conserved (Fig. 7A and data not shown). 
Particularly, the positions for the last four residues are completely conserved among all 
groups (Fig. 7B). Despite the conservation in the number and position of residues, the 
overall sequence identity among groups is very low, with only 20 to 30% identity.  
Interestingly, similar conservation patterns also exist between all these groups and 
several known protease inhibitors from the Ascaris trypsin inhibitor family (Fig. 7B). 
This observation indicates that the five groups from the Hessian fly may also be protease 
inhibitors. Indeed, database searching revealed that the number and position of cysteine 
residues are 100% conserved between some members from the five groups and known 
protease inhibitors or protease inhibitor-like proteins in the database (Fig. 7C). 
 
 4.3 Inhibitory activity of recombinant proteins towards serine proteases 
Structural conservation between the identified proteins and known protease 
inhibitors suggested that the putative proteins might be protease inhibitors as well. To 
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determine if this is the case, two cDNAs from two different groups were selected to 
generate recombinant proteins for activity assays.  
4.3.1 Generation of Recombinant Proteins. Individual expression constructs 
were made using the pCRT7NTTOPO® expression system. The constructs were 
introduced into E. coli strains, and high yield expression of recombinant protein was 
achieved under induced conditions. Figure 8 shows the total proteins from E. coli that 
contain 11A6 and 14A4 constructs under induced or uninduced conditions along with a 
positive control (8A3-1C). The protein profile is similar in uninduced and induced 
samples, except for the presence of one additional protein band in the induced cells. This 
extra band in each of the induced lane represents the recombinant protein 11A6 or 14A4. 
The molecular masses of the induced proteins are of the expected size.  
4.3.2 Purification of Recombinant Proteins. To purify the recombinant proteins 
11A6 and 14A4, bacteria containing the respective constructs were grown in a large 
volume of LB medium and were induced by adding IPTG. The cells were lysed, 
sonicated and centrifuged. 
The protein extracts were used for purification using the ProBondTM purification 
system (Invitrogen, Carlsbad, CA) following the protocol provided by the manufacturer, 
with a few modifications as mentioned in the methods. Protein extracts containing fusion 
proteins were passed through the nickel column to purify 11A6 or 14A4 recombinant 
proteins separately. A single step purified the recombinant proteins to homogeneity. 
Mature proteins were obtained by removing the N-terminal fusion part using enterokinase 
enzyme. The recombinant proteins with and without the N-terminal His-tag are shown in 
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Fig. 9. The sizes of the purified recombinant proteins were as expected. Large amounts of 
mature proteins were obtained by scaling up.  
4.3.3 Inhibitory Activity of Recombinant Protein 11A6. To determine if the 
recombinant proteins are indeed protease inhibitors, inhibition assays with the 
recombinant proteins were conducted against various proteases. As shown in Fig. 10, 
recombinant protein 11A6 inhibited the trypsin activity as much as 62% at a molar ratio 
1.54:1. The IC50 (amount of inhibitor required to inhibit the 50% of enzyme activity) for 
trypsin is 0.52 µM (Table 1). Surprisingly, 11A6 also inhibited papain, (a cysteine 
protease) by ~30%. The 11A6 inhibitor was ineffective against chymotrypsin. The 11A6 
protein inhibited the Hessian fly protease activity in gut extract by 35%. The protein also 
inhibited gut proteases of red flour beetle, Tribolium castaneum, and yellow meal worm, 
Tenebrio molitor, by 82% and 60%, respectively.  
The impact of 11A6 protein on trypsin activity was examined. As shown in the 
Fig. 11 a gradual decrease in trypsin enzymatic activity was observed with the increase in 
inhibitor concentration within the molar ratio from 0:1 to 3.1:1. The trypsin activity 
decreased to 37.89% at a molar ratio of 1.5:1. After that further increase in inhibitor 
concentration had almost no impact on trypsin enzymatic activity. 
The inhibition of papain by 11A6 protein was much less than that of trypsin. As 
shown in Fig. 12, the activity of papain activity was decreased to ~70% at a 1.5:1 molar 
ratio.   
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4.3.4 Inhibitory Activity of Recombinant Protein 14A4. As shown in Fig. 13, 
recombinant protein 14A4 inhibited trypsin activity as much as ~68% and chymotrypsin 
activity by 54% at a molar ration of 3.2:1. The IC50 values for trypsin and chymotrypsin 
are 0.9 and 2.32 µM, respectively (Table 1). 14A4 had no significant impact on the 
activity of papain. Recombinant protein 14A4 also inhibited the protease activity in gut 
extracts from Hessian fly, red flour beetle and yellowmeal worm. The 14A4 protein 
inhibited Hessian fly protease activity as much as 62%, red flour beetle 82%, and yellow 
meal worm by 86%.  
Figure 14 shows the effect of recombinant 14A4 protein on activity of trypsin. 
The molar ratio of inhibitor to trypsin was increased gradually from 0:1 to 4.1:1. With an 
increase in ratio of inhibitor to enzyme, trypsin activity was decreased. Trypsin activity 
was 32.54% at a molar ratio of 3.1:1 (Table 1). No further increase in inhibition was 
observed beyond this molar ratio. 
The effect of the 14A4 protein on the activity of chymotrypsin was studied (Fig. 
15). The molar ratio of 14A4 to chymotrypsin increased gradually from 0:1 to 4.3:1. The 
chymotrypsin activity decreased gradually with an increase in inhibitor, and the activity 
was 45.75% at a molar ratio of 3.2:1 (Table 1). Little further increase in inhibition was 
observed beyond this molar ratio. 
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4.4 Developmental regulation of gene expression 
Northern blot analysis was conducted to study the differential gene expression 
profile in different developmental stages of the insect. The RNA was extracted from 
different larval stages, pupa and adult of Hessian fly and blots were prepared as 
mentioned in methods. The blots were hybridized with their respective P32 labeled cDNA 
probes. 18S RNA was used as control to show equal loading. As shown in Fig. 16, all the 
protease inhibitor genes were exclusively expressed in the larval stages of the insect 
except group I and group V, which are also expressed in the pupal stage. The expression 
patterns varied widely among different inhibitor groups.  
The group I genes are abundantly expressed from 4-12 days, weakly expressed in 
pupa. The highest level of RNA was detected in 6-day old larvae when the larva transists 
from first to second instar. No RNA could be detected in 0- to 2- day old larvae.  
The expression of the genes in group II was detected in 0-day old larvae, but the 
expression level was significantly elevated in 2-day and 4-day old larvae. No RNA could 
be detected in 12 day old larvae, pupae and adults.  
The expression profiles of group III and group IV genes were similar. Very low 
level expression of genes was detected in 2-day old larvae. The expression level 
gradually increased as the larvae became older and reached a maximum in 4-day old 
larvae. After that the expression level decreased and became undetectable in pupae and 
adults.  
The expression of group V genes was observed only in later instar larvae and 
pupae. The RNA was found abundantly in 12-day larvae and pupae. No RNA was 
detected in 0-, 2-, and 4-day old larvae as well as in adult.  
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4.5 Tissue specific expression  
To quantitatively determine transcript levels in different tissues of the larva, real-
time PCR was conducted with primers specific to each of the five groups. The plasmids 
containing their respective cDNAs were used to generate Ct values. The Ct (it is the point 
at which the fluorescence crosses the threshold line) values of the amplification curves 
were used to plot against the log copy number to generate a standard curve and linear 
regression equation for each gene. The regression equation was used to determine the 
copy number of genes in different tissues.  
Figure 17B, 18B and 20B shows the expression profile of group I, group II and 
group IV genes in different tissue types. The expression profiles for all three gene groups 
were similar in different tissues. All the gene groups were expressed in malpighian 
tubules with the highest copy number. Apart from malpighian tubules, they were also 
expressed in midgut and salivary glands but at a low level. The copy number of the 
respective genes in midgut and salivary glands were similar. A very low level of 
expression was observed in fatbody and carcass tissues.  
The tissue specific expression profile of group III genes is shown in Fig. 19B. The 
genes were expressed in malpighian tubules at a high level, followed by midgut and 
salivary glands. The expression was again very low in fatbody and carcass. 
A different expression profile was observed for group V genes. The gene group 
was predominantly expressed in salivary glands followed by fatbody and malpighian 
tubules (Fig. 21B). A low level of expression was detected in the midgut and carcass.  
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4.6 Immunolocalization of 14A4 
Due to limitation of resources, only one antibody was generated. The antibody 
was produced against 20 amino acid peptides synthesized according to the 14A4 protein. 
The antibody was affinity purified against the same peptide. Insect tissues including 
malpighian tubules, salivary glands, and midgut were dissected from the first instar larvae 
and used for histochemical studies. 
As shown in Fig. 22, the 14A4 protein was predominantly present in the 
malpighian tubule. Within this tissue, the protein was predominantly localized at the tip 
and in the middle segment of the tubule. Within these two regions, the protein was 
present in a few cells that are located at the tip whereas in the middle segment the protein 
was present in a greater number of cells. Also the protein was abundantly present in these 
cells. A low level of protein was detected in the midgut cell (Fig. 23).  The figure shows 
the enlarged midgut cell. In the midgut the protein was distributed through out the 
cytoplasm as indicated by the presence of small specks of granules. Inside the cytoplasm, 
the protein was concentrated in some areas. No protein could be detected in the nucleus. 
Very low levels of protein were detected in the salivary gland (Fig. 24). The protein was 
detected in the cells located at the bottom of the basal region and also in the tubular cells.  
Western analysis was conducted to confirm the localization of 14A4 protein in 
different tissues and to check the specificity of 14A4 antibody. Immunoblot data shows 
that the 14A4 was present in the hemolymph, midgut, and midgut extract in large 
amounts whereas in salivary glands lesser amounts of the inhibitor were found (Fig. 25). 
The presence of protein in low amounts in salivary glands was in agreement with the 
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localization data. The specificity of 14A4 antibody was confirmed with the presence of a 
bright 14A4 recombinant protein band.  
 
4.7 Organization of genes 
4.7.1 Identification of positive BAC clones. The variations in deduced amino 
acid sequence of cDNAs of a given group suggested that they might be members of a 
family of genes. To test this hypothesis, an Hessian fly BAC DNA library was analyzed 
through hybridization using P32 labeled 11A6 and 14A4 cDNAs as probes. Probe 11A6 
identified six BAC clones which were named 2J21, 2M12, 7H20, 8L4, 8L18, and 8D19 
(Figure 26). Similarly, probe 14A4 identified five positive BAC clones which were 
named 9O13, 10O2, 11O4, 14C5, and 15M14 (Fig. 27). 
4.7.2 Southern Blot analysis of positive BAC clones. Multiple BAC clones 
positive to 11A6 and 14A4 probes were subjected to Southern analysis. For the 11A6 
probe, a single band was observed in all three BACs that were cut with two different 
restriction enzymes (Fig. 28). The sizes of the DNA fragments that were positive to probe 
11A6 were ~1 and ~2.5 kb for EcoRI and HindIII, respectively.  
 For the 14A4 probe, a different hybridization pattern was observed (Fig. 29). In 
this case, multiple bands with size ranging from 0.5 to 3 kb were detected in each BAC 
cut with different restriction enzymes. When BAC clones were digested with EcoRI, 3 to 
4 positive bands were detected. The hybridization pattern was similar for each BAC. 
However, when the BAC clones were digested with HindIII, the hybridization bands 
were larger in size and pattern varied for different BACs.  
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Figure 1: Phylogenetic analysis of proteins encoded by the cDNAs. Boot strap values are 
indicated at the branching sites. Phylogenetic tree shows three lineages. One of the 
lineages (Lineage II) contains 3 sublineages. The three sublineages in lineage II together 
with lineage I and lineage III represent five different linkage groups, Group I - V. 
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Figure 2A: Nucleotide and amino acid sequence of a representative cDNA from Group I. 
The amino acid is shown under the nucleotide sequence. Signal peptide is denoted by 
underline. * indicates the stop codon. Cysteine residues are in bold letters.  
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11A6 
 
 
-52         ccggggaccgtctatagttttttcgaatagaaaatagaagcttctgtacgat 
                                        * 
1   atggattcgaaaatgttcttattgatggtcgctgcgttgacagtattttggattacatca 
     M  D  S  K  M  F  L  L  M  V  A  A  L  T  V  F  W  I  T  S   
 
61  ggtattgcggcaccgttggcggaagatgagccagtcgatagaacatgtacaagactaaat 
     G  I  A  A  P  L  A  E  D  E  P  V  D  R  T  C  T  R  L  N   
 
121 gagttttacgcagaacgctcaagtcgttgtgatgacaaatactgtgacggtagcgaaata 
     E  F  Y  A  E  R  S  S  R  C  D  D  K  Y  C  D  G  S  E  I   
  
181 tatatgaagtgcactcaagattgtagtcatggatacagatgccgttgtataacaggaaca 
     Y  M  K  C  T  Q  D  C  S  H  G  Y  R  C  R  C  I  T  G  T   
 
241 aagagagattcccacggcaattgcatcgaagagaataaatgtaatgctacaaaattgtgg 
     K  R  D  S  H  G  N  C  I  E  E  N  K  C  N  A  T  K  L  W   
 
301 ctttgagtgtgttagaactatatttcggctggttatgtggcgatagtttcatttggtaga 
     L  *    
 
361 agttta
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Figure 2B: Sequence alignment of putative proteins encoded by Group I cDNAs. Sequence 
variations among group members are bold and underlined.  N-terminal signal peptide is bold 
and underlined. P1 represent the putative amino acid residue at the reactive site center. Grey 
boxes represent the conserved cysteine residues. 
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                   1                                                                                                                                                                      P1                       65 
11a6    MDSKMFLLMVAALTVFWITSGIAAPLAEDEPVDRTCTRLNEFYAERSSRCDDKYCDGSEI 
18g3    MDSKMFLLMVAALTVFWITSGIAAPLAEDEPVDRTCRRLNEFYVECSSRCDDKYCDGSEI 
20c12   MDSKMFLLMVAALTVFWITSGIAAPLAEDEPVDRTCRRLNEFYVECSSRCDDKYCDGSEI 
L7G8    MDSKMFLLMVAALTVFWITSGIAAPLAEDEPVDRTCRRLNEFYVECSSRCDDKYCDGSEI 
L5H2    MDSKMFSLMLAALTVFWITSGIAAPLAEDEPVDRTCRRLNEFYVECSSRCDDKYCDGSEI 
L8C3    MDSKMFLLMVAALTVFWITSGIAAPLADDEPVERTCRRLNEFYVECSSRCDDKYCDGSEI 
29E7    MDSKMFLLMVAALTVFWITSGIAAPLAEDEPVDRTCRRLNEFYVECSSRCDDKYCDGSEI 
S14E3   MDSKMFLLMVAALTVFWITSGIAAPLEEDEPVDRTCRRLNEFYVECSSRCDDKYCDGSEI 
S22F4   MDSKMFLLMVAALTVFWVTSGIAAPLEEDEPVDRTCRRLNEFYVECSGRCDDKYCDGSEI 
Sg8C3   MDSKMFLLMVAALTVFWITSGIAAPLEEDEPVDRTCRRLNEFYVECSNRCDDKYCDGSEI 
 
 
        66                                                     106 
11a6    YMKCTQDCSHGYRCRCITGTKRDSHGNCIEENKCNATKLWL 
18g3    YMKCTQDCSHGYRCRCITGTKRDSHGNCIEENKCNATKLWL  
20c12   YMKCTQDCSHGYRCRCIPGTKRDSHGNCIEENKCNATKLWL 
L7G8    YMKCTQDCSHGYRCRCITGTKRDSHGNCIEENKCNATKLWL 
L5H2    YMKCTQDCSHGYRCRCITGTKRDSHGNCIEENKCNATKLWL 
L8C3    YMKCTQDCSHGYRCRCITGTKRDSHGNCIEENKCNATKLWL 
29E7    YMKCTQDCSHGYRCRCITGTKRDSHGNCIEENKCNATKLWL  
S14E3   YMKCTQDCSHGYRCRCKTGTKRDSRGNCIEENKCNTTKLWL 
S22F4   YMKCTQDCSHGYRCRCKTGTKRDSRGNCIEENKCNATKLWL 
Sg8C3   YMKCTQDCSHGYRCRCKTGTKRDSRGNCIEENKCNTTKLWL 
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Figure 2C: Nucleotide sequence alignment of Group I cDNAs. Sequence variations among 
group members are bold and colored.  The 5’ inframe stop codon, start codon, stop codon 
and poly (A) tail signal are bold and underlined.  
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       1                                                          60 
11A6   attacggccggggaccgtctatagttttttcgaatagaaaatagaagcttctgtacgata
18g3   ----------------gtctatagttttttcgaatagaaaatagaagcttctgtacgata 
20C12  ----------------gtctatagttttttcgaatagaaaatagaagcttctgtacgata 
L7G8   --------------cagtctatagttttttcgaatagaaaatagaagcttctgtacgata 
L5H2   --------------cagtctatagttttttcgaatagaaaatagaagcttctgtacgata 
L8C3   --------------cagtctatagttttttcgaatagaaaatagaagcttctgtacgata 
29E7   --------------cagtctatagttttttcgaatagaaaatagaagcttctgtacgata 
S14E3  --------------cagtctatagttttttcgaatagaaaatagaagcttctgtacgata 
S22F4  ---------------agtctatagttttttcgaatagaaaatagaagcttctgtacgata 
Sg8C3  --------------cagtctatagttttttcgaatagaaaatagaagcttctgtacgata 
 
       61                                                         120 
11A6   tggattcgaaaatgttcttattgatggtcgctgcgttgacagtattttggattacatcag 
18g3   tggattcgaaaatgtttttattgatggtcgctgcgttgactgtattttggattacatcag 
20C12  tggattcgaaaatgtttttattgatggtcgctgcgttgacagtattttggattacatcag 
L7G8   tggattcgaaaatgtttttactgatggtcgctgcgttgacagtattttggattacatcag 
L5H2   tggattcgaaaatgttttcattgatgcttgctgcgttgacagtattttggattacatcag 
L8C3   tggattcgaaaatgtttttattgatggtcgctgcgttgacagtattttggattacatcag 
29E7   tggattcgaaaatgtttttattgatggtcgctgcgttgacagtattttggattacatcag 
S14E3  tggattcgaaaatgtttttattgatggttgctgcgttgacagtattttggattacatcag 
S22F4  tggattcgaaaatgtttttattgatggttgctgcgttgacagtattttgggttacatcag 
Sg8C3  tggattcgaaaatgtttttattgatggttgctgcgttgacagtattttggattacatcag 
 
       121                                                        180 
11A6   gtattgcggcaccgttggcggaagatgagccagtcgatagaacatgtacaagactaaatg 
18g3   gtattgcggcaccgttggcggaagatgagccagtcgatagaacatgtagaagactaaatg 
20C12  gtattgcggcaccgttggcggaagatgagccagtcgatagaacatgtagaagactaaatg 
L7G8   gtattgcggcaccgttggcggaagatgagccagtcgatagaacatgtagaagactaaatg 
L5H2   gtattgcggcaccgttggcggaagatgagccagtcgatagaacatgtagaagactaaatg 
L8C3   gtattgcggcaccgttggcggatgatgagccagtcgaaagaacatgtagaagactaaatg 
29E7   gtattgcggcaccgttggcggaagatgagccagtcgatagaacatgtagaagactaaatg 
S14E3  gtattgcc agcaccgttgg ggaagatgagccagtcgatagaacatgtagaagactaaatg 
S22F4  gtattgccgcaccgttggaggaagatgagccagtcgatagaacatgtagaagactaaatg 
Sg8C3  gtattgccgcaccgttggaggaagatgagccagtcgatagaacatgtagaagactaaatg 
 
       181                                                        240 
11A6   agttttacgcagaacgctcaagtcgttgtgatgacaaatactgtgacggtagcgaaatat 
18g3   agttttacgtagaatgctcaagtcgttgtgatgacaaatactgtgacggtagcgaaatat 
20C12  agttttacgtagaatgctcaagtcgttgtgatgacaaatactgtgacggtagcgaaatat 
L7G8   agttttacgtagaatgctcaagtcgttgtgatgacaaatactgtgacggtagcgaaatat 
L5H2   agttttacgtagaatgctcaagtcgttgtgatgacaaatactgtgacggtagcgaaatat 
L8C3   agttttacgtagaatgctcaagtcgttgtgatgacaaatactgtgacggtagcgaaatat 
29E7   agttttacgtagaatgctcaagtcgttgtgatgacaaatactgtgacggtagcgaaatat 
S14E3  agttttacgtagaatgctcaagtcgttgtgatgacaaatactgtgacggtagcgaaatat 
S22F4  agttttacgtagaatgctcaggtcgttgtgatgacaaatactgtgacggtagcgaaatat 
Sg8C3  agttttacgtagaatgctcaaatcgttgtgatgacaaatactgtgacggtagcgaaatat 
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       241                                                        300 
11A6   atatgaagtgcactcaagattgtagtcatggatacagatgccgttgtataacaggaacaa 
18g3   atatgaagtgcacacaagattgtagtcatggatacagatgccgttgtataacaggaacaa 
20C12  atatgaagtgcacacaagattgtagtcatggatacagatgccgttgtataccaggaacaa 
L7G8   atatgaagtgcacacaagattgtagtcatggatacagatgccgttgtataacaggaacaa 
L5H2   atatgaagtgcacacaagattgtagtcatggatacagatgccgttgtataacaggaacaa 
L8C3   atatgaagtgcacacaagattgtagtcatggatacagatgccgttgtataacaggtacaa 
29E7   atatgaagtgcacacaagattgtagtcatggatacagatgccgttgtataacaggaacaa 
S14E3  atatgaagtgcacacaagattgtagtcatggatacagatgccgttgtaaaacaggtacaa 
S22F4  atatgaagtgcacacaagattgtagtcatggatacagatgccgttgtaaaacaggtacaa 
Sg8C3  atatgaagtgcacacaagattgtagtcatggatacagatgccgttgtaaaacaggtacaa 
 
       301                                                        360 
11A6   agagagattcccacggcaattgcatcgaagagaataaatgtaatgctacaaaa-ttgtgg 
18g3   agagagattcccacggcaattgcatcgaagagaataaatgtaatgctacxaaaattgtgg 
20C12  agagagattcccacggcaattgcatcgaagagaataaatgtaatgctacaaaa-ttgtgg 
L7G8   agagagattcccacggcaattgcatcgaagagaataaatgtaatgctacaaaa-ttgtgg 
L5H2   agagagattcccacggcaattgcatcgaagagaataaatgtaatgctacaaaa-ttgtgg 
L8C3   agagagattcccacggcaattgcatcgaagagaataaatgtaatgctacaaaa-ttgtgg 
29E7   agagagattcccacggcaattgcatcgaagagaataaatgtaatgctacaaaa-ttgtgg 
S14E3  agagagattcccgcggcaattgcatcgaagagaataaatgtaatactacaaaa-ttgtgg 
S22F4  agagagattcccgcggcaattgcatcgaagagaataaatgtaatgctacaaaa-ttgtgg 
Sg8C3  agagagattcccgcggcaattgcatcgaagagaataaatgtaatactacaaaa-ttgtgg 
 
       361                                                        420 
11A6   ctttgagtgtgttagaactatatttcggctggttatgtggcgatagtttcatttggtag- 
18g3   ctttgagtgtgttagaactatatttcggttggttatgtggcgatagtttcatttggtaa- 
20C12  ctttgagtgtgttagaactatatttcggttggttatgtggcgatagtttcattcggtaa- 
L7G8   ctttgagtgtgttagaactatatttcggttggttatgtggcgatagtttcatttggtaa- 
L5H2   ctttgagtgtgttagaactatatttcggttggttatgtggcga-ggtggca---ggaaat 
L8C3   ctttgagtgtgttagaactatatttcggttggttatgtggcgatagtttcatttggtaa- 
29E7   ctttgagtgtgttagaactatatttcggttggttatgtggcgatagtttcatttggtaa- 
S14E3  ctttgagtgtgttggaactatatttcggttggttatgtggcgatggtttcatttggtga- 
S22F4  ctttgagtgtgttagaactatatttcggttggttatgtggcgatggtttcatttggtga- 
Sg8C3  ctttgagtgtgttggaactatatttcggttggttatgtggcgatggtttcatttggtga- 
 
       421                                                        480 
11A6   aa-gttta---------------------------------------------------- 
18g3   aa-gttt----aaataaagtttattttgg---------------gg----aatatgtc-- 
20C12  aa-gttt----aaataaagtttattttgg---------------gg----aatatgtc-- 
L7G8   aa t aaataa t attttgg gg aatat ct - -g tt---- ag tt --------------- ---- g -
L5H2   aatgtatgaagaaataatgtatatttttttttgaaataaaatatggtctgaatatatgta 
L8C3   aaagttt----aaataaagtttattttgg---------------ggg---aatataccca 
29E7   aa-gttt----aaataaagtttattttgg---------------gg----aatatgtcta 
S14E3  aa-gttt----aaataaagtttattttgg---------------gg----aatatggcaa 
S22F4  aa-gttt----aaataaagtttattttgg---------------gg----aatatgtcca 
Sg8C3  aa-gttt----aaataaagtttattttgg---------------gg----aatatgtcaa 
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Figure 3A: Nucleotide and amino acid sequence of a representative cDNA from Group II. 
The amino acid is shown under the nucleotide sequence. Signal peptide is denoted by 
underline. * indicates the stop codon. Cysteine residues are in bold letters.  
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14A4 
 
 
-69                                                    atatctacg 
 
-60 aggactattgctggactctgaacgtgtttaatattcgaagaaaagaaaaataatcctaaa 
                       * 
1   atgtctttgaaattggttataattggagtcgccctgctcggcttcgttgcatcttcattg 
     M  S  L  K  L  V  I  I  G  V  A  L  L  G  F  V  A  S  S  L   
 
61  ggtaatgaagacaacaaaccaaacttatgttgtcctcaaaacgaaaaactttatgactat 
     G  N  E  D  N  K  P  N  L  C  C  P  Q  N  E  K  L  Y  D  Y   
 
121 cattatccgtgcaaaaaaaacatgtgcaaagactattacgaccattccagtcaaaacgaa 
     H  Y  P  C  K  K  N  M  C  K  D  Y  Y  D  H  S  S  Q  N  E   
 
181 tgcaaacttccggccacttttgctaaaaacaaatattgcgattgtaaggatggttactta 
     C  K  L  P  A  T  F  A  K  N  K  Y  C  D  C  K  D  G  Y  L   
 
241 cgcactaatgcaggtccttgtgttaagaaagaagattgcaatttcttgataaaaaatgag 
     R  T  N  A  G  P  C  V  K  K  E  D  C  N  F  L  I  K  N  E   
 
301 catcattgatttgaaatgaaacgcaactgataaggaattggcaatgataaaaaaactgta 
     H  H  *  
 
361 tccaaatctttaacaatttaaaaataaagcaaaataaaaattccattttcctggtgaagg 
 
421 gaacaacttgc
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Figure 3B: Sequence alignment of putative proteins encoded by Group II cDNAs. Sequence 
variations among group members are bold and underlined.  N-terminal signal peptide is bold 
and underlined. P1 represent the putative amino acid residue at the reactive site center. Grey 
boxes represent the conserved cysteine residues. 
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            1                                                                           P1   55 
14a4    MSLKLVIIGVALLGFVASSL------GNEDNKPNLCCPQNEKLYDYHYPCKKNMC 
Lg1A1   MSLKLVIIGVALLGFVASSL------GNEDNKPNLCCPQNEKLYDYHYPCKKNMC 
Lg4h7   MSLKLVIIGVALLGFVASSL------GYEDNKPNLCCPQNEKLYDYHYPCKKNMC 
Lg4C9   MSLKLVIIGVALLGFVASSL------GYEDSKPNLCCPQNEKLYDYHYPCKKNMC 
Pg10a9  MSLKLVIIGVALLGFVASSL------GYEDNKPNLCCPQNEKLYDYHYPCKKNMC 
S10F3   MSLKLVIIGVALLGFVAFSL------GNEDTKPNLCCPQNEKLYDYHYPCKKNMC 
Sg8F6   MCLKLVIIGVALLGFVASSL------GYEDNKPNLCCPQNEKLYDYHYPCKKNMC 
S17B2   MCLKLVIIGVALLGFVASTFIPLPPSGNEDTKPNLCCPQNEKLYDYNYPCKKNMC 
Sg6G2   MSLKLVIIGVALLGFVASSL------GNEDNKPNFCCPQNEKLYDYNYPCKITMC 
 
            56                                                                              108 
14a4    KDYYDHSSQNECKLPATFAKNKYCDCKDGYLRTNAGPCVKKEDCNFLIKNEHH 
Lg1A1   KDYYDHSSQNECKLPATFAKNKYCDCEDGYLRTNAGPCVKKEDCNFLIKNEHH 
Lg4h7   KDLYDHSSQNECKLPATFAKNKYCDCMDGYLRTNAGPCVKKEDCNFLIKNEHH 
Lg4C9   KDLYDHSSQNECKLPATFAKNKYCDCMDGYLRTNAGPCVKKEDCNFLIKNEHH 
Pg10a9  KDLYDHSSQNECKLPATFAKNKYCDCMDGYLRTNAGPCVEKEDCNFLIKNEHH 
S10F3   KDFYDHSSQTECKLPATFAKNKYCDCMDGYLRTNAGPCVKQEDCNFLIKNKHH 
Sg8F6   KDYYDHSSQNECKLPATFAKNKYCDCMDGFLRTNAGPCVKKEDCNFLIKNEHH 
S17B2   RDFFDYSSKKECNLPATYAKNKYCDCMEGYWRLDDGPCVKSENCDILLQNQNTK
Sg6G2   KDLYDHSKKKECNLPATFAKNKYCECMEGYYHSVKGPCVREEDCNFLI 
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Figure 3C: Nucleotide sequence alignment of Group II cDNAs. Sequence variations among 
group members are bold and colored.  The 5’ inframe stop codon, start codon, stop codon 
and poly (A) tail signal are bold and underlined.  
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        1                                                           60   
14A4    -atatctacgaggactattgctggactctgaacgtgtttaatattcgaagaaaagaaaaa 
Lg1A1   --tatcaacgaggactattgctggactctgaacgtgtttaatattcgaagaaaagaaaaa 
Lg4H7   --tatcaacgaggactattgctggactctgaacgtgtttaatattcgaagaaaagaaaaa 
Lg4C9   -atatcaacgaggactattgctggactctgaacgtgtttaatattcgaagaaaagaaaaa 
Pg10a9  --tatcaacgaggactattgctggactctgaacgtgtttaatattcgaagaaaagaagaa 
S10F3   --taacagcaagaactattgctggactctgaacgtgtttaatattcgcagaaaagaaaaa 
Sg8F6   --tatcaacgaggactattgctggactctgaacgtgtttaatattcgaagaaaagaaaaa 
S17B2   gatatcaacgaggactattgctggactctgaacgtgtttaatattcgaagaaaagaaaaa 
Sg6G2   gatatcaacgaggactattgctggactctgaacgtgtttaatattcgaagaaaagaaaaa 
 
        61                                                          120 
14A4    -taatcctaaaatgtctttgaaattggttataattggagtcgccctgctcggcttcgttg 
Lg1A1   -taatcctaaaatgtctttgaaattggttataattggagtcgccctgctcggcttcgttg 
Lg4H7   ataatcctaaaatgtctttgaaattggttataattggagtcgccctgctcggcttcgttg 
Lg4C9   -taatcctaaaatgtctttgaaattggttataattggagtcgccctgctcggcttcgttg 
Pg10a9  -taatcctaaaatgtctttgaaattggttataattggagtcgccctgctcggcttcgttg 
S10F3   -taatcga ggtcgctctgctcggcttcgttg aaaatgtctttgaaattggttataattgg
Sg8F6   -taatccaaaaatgtgtttgaaattggttataattggagtcgccctgctcggcttcgttg 
S17B2   -taatcctaaaatgtgtttgaaattggttataattggagtcgctttgctcggcttcgttg 
Sg6G2   -taatccaaaaatgtctttgaaattggttataattggagtcgctctgcttggcttcgttg 
 
        121                                                        180 
14A4    catcttcatt------------------gggtaatgaagacaacaaaccaaacttatgtt 
Lg1A1   catcttcatt------------------gggtaatgaagacaacaaaccaaacttatgtt 
Lg4H7   catcttcatt------------------gggttatgaagacaacaaaccaaacttatgtt 
Lg4C9   catcttcatt------------------gggtt gcaaaccaaacttatgtt atgaagaca
Pg10a9  catcttcatt------------------gggttatgaagacaacaaaccaaacttatgtt 
S10F3   cattttcatt------------------gggtaatgaagacaccaaaccaaacttatgtt 
Sg8F6   catcttcatt------------------gggttatgaagacaacaaaccaaacttatgtt 
S17B2   catctacattcattccgctacctccatcgggtaatgaagacaccaaaccaaacttatgtt 
Sg6G2   catcttcatt------------------gggtaatgaagacaacaaaccaaacttttgtt 
 
        181                                                        240 
14A4    gtcctcaaaacgaaaaactttatgactatcattatccgtgcaaaaaaaacatgtgcaaag 
Lg1A1   gtcctcaaaacgaaaaactttatgactatcattatccgtgcaaaaaaaacatgtgcaaag 
Lg4H7   gtcctcaaaacgaaaaactttatgactatcattatccgtgcaaaaaaaacatgtgcaaag 
Lg4C9   gtcctcaaaacgaaaaactttatgactatcattatccgtgcaaaaaaaacatgtgcaaag 
Pg10a9  gtcctcaaaacgaaaaactttatgactatcattatccgtgcaaaaaaaacatgtgcaaag 
S10F3   gtcctcaaaacgaaaaactttatgattatcattatccgtgcaaaaaaaacatgtgcaaag 
Sg8F6   gtcctcaaaacgaaaaactttatgactatcattatccgtgcaaaaaaaacatgtgcaaag 
S17B2   gtcctcaaaacgaaaaactttatgat a tagag tat attatccgtgcaaaaaaaacatgtg
Sg6G2   gtcctcaaaacgaaaaactttatgattataattatccgtgcaaaataaccatgtgtaaag 
 
        241                                                        300 
14A4    actattacgaccattccagtcaaaacgaatgcaaacttccggccacttttgctaaaaaca 
Lg1A1   actattacgaccattccagtcaaaacgaatgcaaacttccggccacttttgctaaaaaca 
Lg4H7   acttatacgaccattccagtcaaaacgaatgcaaacttccggccacttttgctaaaaaca 
Lg4C9   acttatacgaccattccagtcaaaacgaatgcaaacttccggccacttttgctaaaaaca 
Pg10a9  acttatacgaccattccagtcaaaacgaatgcaaacttccggccacttttgctaaaaaca 
S10F3   acttttacgaccattccagtcaaaccgaatgcaaacttccggccacttttgctaaaaaca 
Sg8F6   actattacgaccattccagtcaaaacgaatgcaaacttccggccacttttgctaaaaaca 
S17B2   actttttcgactattccagtaagaaggaatgcaatcttccggccacttatgctaaaaaca 
Sg6G2   acttatacgaccattccaaaaagaaggaatgcaatcttccggccacttttgctaaaaaca 
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        301                                                        360 
14A4    aatattgcgattgtaaggatggttacttacgcactaatgcaggtccttgtgttaagaaag 
Lg1A1   aatattgcgattgtgaggatggttacttacgcactaatgcaggtccttgtgttaagaaag 
Lg4H7   aatattgcgattgtatggatggctacttacgcactaatgcaggtccttgtgttaagaaag 
Lg4C9   aatattgcgattgtatggatggctacttacgcactaatgcaggtccttgtgttaagaaag 
Pg10a9  aatattgcgattgtatggatggctacttacgcactaatgcaggtccttgtgttgagaaag 
S10F3   aatattgcgattgtatggatggttacttacgcactaatgcaggtccttgtgttaaacaag 
Sg8F6   aatattgcgattgtatggatggtttcttacgcactaatgcaggtccttgtgttaagaaag 
S17B2   aatattgtgattgtatggaaggttactggcgccttgatgatggtccttgtgttaagagcg 
Sg6G2   aatattgcgaatgtatggaaggttactaccacagtgttaaaggtccttgtgttagagaag 
  
        361                                                        420 
14A4    aagattgcaatttcttgataaaaaatgagcat-c------attgatttgaaatgaaacgc 
Lg1A1   aagattgcaatttcttgataaaaaatgagcat-c------attgatttgaaatgaaacgc 
Lg4H7   aagattgcaatttcttgataaaaaatgagcat-c------attgatttgaaatgaaacgc 
Lg4C9   aagattgcaatttcttgataaaaaatgagcat-c------attgatttgaaatgaaacgc 
Pg10a9  aagattgcaatttcttgataaaaaatgagcat-c------attgatttgaaatgaaacgc 
S10F3   aagattgcaatttcttgataaaaaataagcat-c------attgatttaaaatgaaacgc 
Sg8F6   aagattgcaatttcttgataaaaaatgagcat-c------attgatttgaaatgaaacgc 
S17B2   aaaattgcgatatcttgttacaaaatcagaatacgaaatgattgatttgaaatgaaacgc 
Sg6G2   aagattgcaatttcttgat----------------------tt-----aaaatgaaacgc 
 
        421                                                        480 
14A4    aactgataaggaattggcaatgataaaaaaa---ctgtatccaaatctttaacaatttaa
Lg1A1   Aactgataaggaattggcaatgataaaaaaa---ctgtatccaaatctttaacaatttaa 
Lg4H7   aactgataaggaattggcaacgataaaaaa----ctgtattcaaatttttaacaatttaa 
Lg4C9   aactgataaggaattggcaatgataaaaaa----ctgtattcaaatttttaacaatttaa 
Pg10a9  aactgatgaggaattggcaatgataaaaaa----ctgtattcaaatttttaacaatttaa 
S10F3   aacggataaagaattggcaatgataaaaaaa---ttgtattcaaatctttaacaatttaa 
Sg8F6   aactgataaagaattggcaatgataaaaaa----ctgtattcaaatttttgacaatttaa 
S17B2   aacggataaggaatttgcaatgatgaaaaa----ctgtattcaaatctttaacaatttaa 
Sg6G2   aacggataaagaattggcaatgataaaaaaaaaactgtattcaaatctttaacaatttaa 
 
        481                                               531 
14A4    aaataaagcaaaataaaaattccattttcctggtgaagggaacaacttgca 
Lg1A1   aaataaagcaaaataaaaattccattttcctggtgaagggaacaacttgca 
Lg4H7   aa-taaagcaaaataaaaattccattttcctggtgaagggaacaacttgaa 
Lg4C9   aa-taaagcaaaataaaaattccattttcctggtgaagggaacaacttaaa 
Pg10a9  aa-taaagcaaaaaaaaaa------------------------------aa 
S10F3   aaataaagcaaaataaaaattacattttcctggtgaagggaataacttata 
Sg8F6   aa-taaagcaaaataaaaattccattttcctggtgaagggaacaacttgaa 
S17B2   aa-taaagcaaaataaaaattccatttttctggtgaatggaacaacttaag 
Sg6G2   aa-aaaagcaaaataaaaattccatttttctggtgaagggaaaaa----aa 
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Figure 4A: Nucleotide and amino acid sequence of a representative cDNA from Group 
III. The amino acid is shown under the nucleotide sequence. Signal peptide is denoted by 
underline. * indicates the stop codon. Cysteine residues are in bold letters. 
 
 
 105
  
Lg2A3 
  
-68                                                     tatcaacg 
 
-60 aggactattgctggactctgaacgtatttaatattcgaagcaaagaaaaataatcgaaaa 
                       * 
1   atgtctttgaaattggttataattggaatcgctctgctcggtttcgttgcatcttcattg      
     M  S  L  K  L  V  I  I  G  I  A  L  L  G  F  V  A  S  S  L 
 
61  ggtgaagacgcccaaccaaattcagcttgccctccaaacgaaaccctttatgattttgtc 
     G  E  D  A  Q  P  N  S  A  C  P  P  N  E  T  L  Y  D  F  V 
 
121 gatccgtgcaggaaagacacttgtgaaaaggcaatcaaaaacgtcggattttacgaatgc 
     D  P  C  R  K  D  T  C  E  K  A  I  K  N  V  G  F  Y  E  C  
 
181 ggtggctacaaaactgaacatccagtttgcaattgtgtcgacaacttttatcgcaataaa 
     G  G  Y  K  T  E  H  P  V  C  N  C  V  D  N  F  Y  R  N  K 
 
241 gagggtcactgtgtttcgatagatcaatgcagatcagaaataaatggataaaggcaccgg 
     E  G  H  C  V  S  I  D  Q  C  R  S  E  I  N  G  * 
 
301 aataaaggcaacggataaggaatttgcaatgataaaaaaactgtattcaaatctttaaca 
 
361 atttaaaataaagcaaaataaaaattccatttttctggtgaagggaacaacttcc 
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Figure 4B: Sequence alignment of putative proteins encoded by Group III cDNAs. Sequence 
variations among group members are bold and underlined.  N-terminal signal peptide is bold 
and underlined. P1 represent the putative amino acid residue at the reactive site center. Grey 
boxes represent the conserved cysteine residues. 
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              1                                                                     P1          56 
Lg2A3    MSLKLVIIGIALLGFVASSL---GEDAQPNSACPPNETLYDFVDPCRKDTCEKAIK 
PG10A8   MSLKLVIIGIALLGFVASSL---GEDAQPNSACPPNETLYDFVDPCRKDTCEKAIK 
PG10C11  MSLKLVIIGIALLGFVASSL---GEDAQPNSACPPNETLYDFVDPCRKDTCEKAMK 
PG10G12  MSLKLVIIGIALLGFVASSL---GEDAQPNSACPPNETLYDFVDPCRKDTCEKAMK 
Lg2G2    MSLKLVIIGIALLGFVASAL---GEDTQPNSACPPNETLYDFVDPCRKDTCEKAIK 
Lg2G5    MSLKLVIIGIALLGFVASALDVEGEDTQPNSACPPNETLYDFVDPCRKDTCEKAIK 
Sg6C8    MSLKLVIIGVALLGFVAFSL---GDGTQPNSACPPNETLYDFVDPCRKDTCEKAIK 
          1                                                              99 
Lg2A3    NVGFYECGGYKTEHPVCNCVDNFYRNKEGHCVSIDQCRSEING 
PG10A8   NVGFYECGGYKTEHPVRNCVDNFYRNKEGHCVSIDQCRSEING 
PG10C11  DTGFYECGGHKTEHPVCNCVENTYRNKEGRCVSLDQCKSEING 
PG10G12  DTGFYECGGHKTEHPVCNCVENTYRNKEGRCVSLDQCKSEING 
Lg2G2    NVGFYECGGHKTEHPVCNCVDNMYRNKAGHCVSIDQCRSEING 
Lg2G5    NVGFYECGGHKTEHPVCNCVDNMYRNKAGHCVSIDQCRSEING 
Sg6C8    NIGFYECGGYKVEHPVCNCVDNMYRNKENRCVSIDQCRSEING 
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Figure 4C: Nucleotide sequence alignment of Group III cDNAs. Sequence variations among 
group members are bold and colored.  The 5’ inframe stop codon, start codon, stop codon 
and poly (A) tail signal are bold and underlined.  
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         1                                                          60 
Lg2A3    ---tatcaacgaggactattgctggactctgaacgtatttaatattcgaagcaaagaaaa 
PG10A8   ---tatcaacgaggactattgctggactctgaacgtatttaatattcgaagcaaagaaaa 
PG10C11  ---tatcaacgaggactattgctggactctgaacgtatttaatattcgaagcaaagaaaa 
PG10G12  ---tatcaacgaggactattgctggactctgaacgtatttaatattcgaagcaaagaaaa 
Lg2G2    ---tatcaacgaggacaattgctggactctgaacgtatttaatattcgaagcaaagaaaa 
Lg2G5    -----tcaacgaggacaattgctggactctgaacgtatttaatattcgaagcaaagaaaa 
Sg6C8    tcatatcaacgaggactattgctggactctgaacgaatattaaattcgaagcaaagaaaa 
 
         61                                                         120 
Lg2A3    ataatcgaaaaatgtctttgaaattggttataattggaatcgctctgctcggtttcgttg 
PG10A8   ataatcgaaaaatgtctttgaaattggttataattggaatcgctctgctcggtttcgttg 
PG10C11  ataatcgaaaaatgtctttgaaattggttattattggaatcgctctgctcggcttcgttg 
PG10G12  ataatcgaaaaatgtctttgaaattggttattattggaatcgctctgctcggcttcgttg 
Lg2G2    ataatcgaaaaatgtctttgaaattggttataattggaatcgctctgctcggcttcgttg 
Lg2G5    ataatcgaaaaatgtctttgaaattggttataattggaatcgctctgctcggcttcgttg 
Sg6C8    ataatcgaaaaatgtctttgaaattggttataattggagtcgctctgctcggcttcgttg 
 
         121                                                        180 
Lg2A3    catcttcattgg---------gtgaagacgcccaaccaaattcagcttgccctccaaacg 
PG10A8   catcttcattgg---------gtgaagacgcccaaccaaattcagcttgccctccaaacg 
PG10C11  catcttcattgg---------gtgaagacgcccaaccaaattcagcttgccctccaaacg 
PG10G12  catcttcattgg---------gtgaagacgcccaaccaaattcagcttgccctccaaacg 
Lg2G2    catctg acattgg---------gtgaagac cccaaccaaattcagcttgccctccaaacg 
Lg2G5    catctgcattggatgtggaaggtgaagacacccaaccaaattcagcttgccctccaaacg 
Sg6C8    cattttcattgg---------gtgatggcacccaaccaaattcagcttgccctccaaacg 
 
         181                                                        240 
Lg2A3    aaaccctttatgattttgtcgatccgtgcaggaaagacacttgtgaaaaggcaatcaaaa 
PG10A8   aaaccctttatgattttgtcgatccgtgcaggaaagacacttgtgaaaaggcaatcaaaa 
PG10C11  aaaccctttatgattttgtcgatccgtgcaggaaagacacttgtgaaaaggcaatgaaag 
PG10G12  aaaccctttatgattttgtcgatccgtgcaggaaagacacttgtgaaaaggcaatgaaag 
Lg2G2    aaaccctttatgattttgtcgatccgtgcagaaaagacacttgtgaaaaggcaatcaaaa 
Lg2G5    aaaccctttatgattttgtcgatccgtgcagaaaagacacttgtgaaaaggcaatcaaaa 
Sg6C8    aaaccctttatgatttcgtcgatccgtgcaggaaagacacttgtgaaaaggcaatcaaaa 
 
         241                                                        300 
Lg2A3    acgtcggattttacgaatgcggtggctacaaaactgaacatccagtttgcaattgtgtcg 
PG10A8   acgtcggattttacgaatgcggtggctacaaaactgaacatccagttcgcaattgtgtcg 
PG10C11  acaccggattttacgaatgcgggggccacaaaactgaacatccagtttgcaattgtgtcg 
PG10G12  acaccggattttacgaatgcgggggccacaaaactgaacatccagtttgcaattgtgtcg 
Lg2G2    acgtcggattttacgaatgcgggggccacaaaactgaacatccagtttgcaattgtgtcg 
Lg2G5    acgtcggattttacgaatgcgggggccacaaaactgaacatccagtttgcaattgtgtcg 
Sg6C8    acatcggattttacgaatgcgggggctacaaagttgaacatccagtttgcaattgtgtcg 
 
         301                                                        360 
Lg2A3    acaacttttatcgcaataaagagggtcactgtgtttcgatagatcaatgcagatcagaaa 
PG10A8   acaact ttatcgcaataaagagggtcactgtgtttcgatagatcaatgcagatcagaaa t
PG10C11  aaaacacgtatcgcaataaagaaggtcgctgtgtttcgttggatcaatgcaaatcagaaa 
PG10G12  aaaacacgtatcgcaataaagaaggtcgctgtgtttcgttggatcaatgcaaatcagaaa 
Lg2G2    acaatatgtatcgcaataaagcgggtcactgtgtttcgatagatcaatgccgatcagaaa 
Lg2G5    acaatatgtatcgcaataaagcgggtcactgtgtttcgatagatcaatgccgatcagaaa 
Sg6C8    acaatatgtatcgcaataaagagaatcgctgtgtttcgatagatcaatgcagatcagaaa 
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         361                                                        420 
Lg2A3    taaatggataaaggcaccggaataaaggcaacggataaggaatttgcaatgataaaaaaa 
PG10A8   taaatggataaaggcaccggaataaaggcaacggataaggaatttgcaatgataaaaaaa 
PG10C11  taaatggataaaggcaacggaataaaggcaacggataaggaattggcaatgataaaaaa- 
PG10G12  taaatggataaaggcaacggaataaaggcaacggataaggaattggcaatgataaaaaa- 
Lg2G2    taaatggataaaggcaacggaataaaggcaacggataaggaattggcaatgataaaaaaa 
Lg2G5    taaatggataaaggcaacggaataaaggcaacggataaggaattggcaatgataaaaaaa 
Sg6C8    taaatggataaaggcaatggaataaaggcaacggataaggaattggcaatgataaaaaaa 
 
 
         421                                                        480 
Lg2A3    -ctgtattcaaatctttaacaatttaaaataaagcaaaataaaaattccatttttctggt 
PG10A8   -ctgtattcaaatctttaacaatttaaaataaagcaaaataaaaattccatttttctggt 
PG10C11  -ctgtattcaaatctttaaaaatttaaaataaagcaaaataaaaattccatttttctggt 
PG10G12  -ctgtattcaaatctttaaaaatttaaaataaagcaaaataaaaattccatttttctggt 
Lg2G2    actgtattcaaatctttaacaatttaaaataaagcaaaataaaaattccatttttctggt 
Lg2G5    actgtattcaaatctttaacaatttaaaataaagcaaaataaaaattccatttttctggt 
Sg6C8    actgtattcaaatctttta--atttaaaataaagcaaaataaaaattccatttttctggt 
 
 
         481                    504 
Lg2A3    gaagggaacaacttccaaaaaaaa 
PG10A8   gaagggaacaacttgcaaaaaaaa 
PG10C11  gaagggaa--------aaaaaaaa 
PG10G12  gaagggaacaacttgcaaaaaaaa 
Lg2G2    gaagggaacaacttgcaaaaaaga 
Lg2G5    gaagggaacaacttgcataaaaaa 
Sg6C8    gaagggaacaacttg-ataaaaaa
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Figure 5A: Nucleotide and amino acid sequence of a representative cDNA from Group 
IV. The amino acid is shown under the nucleotide sequence. Signal peptide is denoted by 
underline. * indicates the stop codon. Cysteine residues are in bold letters. 
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Lg2F7 
    
 
-112         ccagtgtgatggatatctgcagaattcgcccttaagcagtggtatcaacgc 
                    * 
-60 agagtggccattaccgcgagaacgtgtttaatattcgaagaaaagaaaaataatccaaaa 
 
1   atgtgtttgaaattgcttataattggaattgctctgctcgtcttcgttacatcttcattg 
     M  C  L  K  L  L  I  I  G  I  A  L  L  V  F  V  T  S  S  L 
 
61  ggtgaatgtaatcaagacatccaatcaaagaactgttgtcctgaaaacgaaacactttat 
     G  E  C  N  Q  D  I  Q  S  K  N  C  C  P  E  N  E  T  L  Y 
 
121 gatcatgattatccgtgcgctagagacacttgtgcaaaggcattcgacgaccccgcattt 
     D  H  D  Y  P  C  A  R  D  T  C  A  K  A  F  D  D  P  A  F 
 
181 tacgaatgcaaatttgtggcacaaaaatctaaatttcgatattgcaattgtaacgacaat 
     Y  E  C  K  F  V  A  Q  K  S  K  F  R  Y  C  N  C  N  D  N 
 
241 atgtttcgcaataaagatggttactgtgtttcgattgaacaatgcttattagaaataaat 
     M  F  R  N  K  D  G  Y  C  V  S  I  E  Q  C  L  L  E  I  N 
 
301 ggttcaatatgaaaggcaacagaaaaggaatttccaatgatagaaaagtgtattcaaatc 
     G  S  I  *  
     
361 tttaacaatttaaaataaaggaaaataaaaaaaattctttgtttttggtgaaggcaacaa 
 
421 ctt 
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Figure 5B: Sequence alignment of putative proteins encoded by Group IV cDNAs. Sequence 
variations among group members are bold and underlined.  N-terminal signal peptide is bold 
and underlined. P1 represent the putative amino acid residue at the reactive site center. Grey 
boxes represent the conserved cysteine residues. 
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Figure 5C: Nucleotide sequence alignment of Group IV cDNAs. Sequence variations 
among group members are bold and colored.  The 5’ inframe stop codon, start codon, 
stop codon and poly (A) signal are bold and underlined.  
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       1                                                          60 
Lg2F7  ccagtgtgatggatatctgcagaattcgcccttaagcagtggtatcaacgcagagtggcc 
Pg7f5  --------------------------------------------------catattagca 
 
       61                                                         120 
Lg2F7  a---ttaccgcgagaacgtgtttaatattcga cagaaaagaaaaataat caaaaatgtgt 
Pg7f5  agaattattgccggactctg---aacgt--gtagaaaagaaaaataattcaaaaatgtct 
 
       121                                                        180 
Lg2F7  ttgaaattgcttataattggaattgctctgctcgtcttcgttacatcttcattgggtgaa 
Pg7f5  ttgaaattggttataattggaattgctctgcatgtcttcgttacatcttcattgggtgaa 
 
       181                                                        240 
Lg2F7  tgtaatcaagacatccaatcaaagaactgttgtcctgaaaacgaaacactttatgatcat 
Pg7f5  tgtaaccaagacttccaatcaaagaactgttgtcctcaaaacgaaatactttatgatcat 
 
       241                                                        300 
Lg2F7  gattatccgtgcgctagagacacttgtgcaaaggcattcgacgaccccgcattttacgaa 
Pg7f5  gattatccgtgcgctagagacacttgtgcaaaggcattcgacgaccccgcattttacgaa 
 
       301                                                        360 
Lg2F7  tgcaaatttgtggcacaaaaatctaaatttcgatattgcaattgtaacgacaatatgttt 
Pg7f5  tgcaaatttgtggcccaaaaatctaaatatcaatattgcaattgtaacgacactatgttt 
 
       361                                                        420 
Lg2F7  cgcaataaagatggttactgtgtttcgattgaacaatgcttattagaaataaatggttca 
Pg7f5  cgcaataaagctggtcagtgtgtttcgatagaagaatgcttattagaaataaatggttca 
 
       421                                                        480 
Lg2F7  atatgaaaggcaacagaaaaggaatttccaatgatagaaaagtgtattcaaatctttaac 
Pg7f5  atatgaaaggtaacggatacggaatttgtaatgatagaaaagtgtattcaaatcttttac 
 
       481                                                        540 
Lg2F7  aatttaaaataaaggaaaataaaaaaaattctttgtttttgg-tgaaggcaacaacttaa 
Pg7f5  aatttaaaataaaggaaaataaaaaaaattctttgtttttgggtgaaggcaacaacttac 
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Figure 6: Nucleotide and amino acid sequence of the only one cDNA from Group V. The 
amino acid is shown under the nucleotide sequence. Signal peptide is denoted by 
underline. * indicates the stop codon. Cysteine residues are in bold letters. 
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11C4 
 
 
-28                                 catatcgtttgttaacttcaacaagaat 
 
1   atgaattcgttaattggtttgattaaaattgttttttttattggaattgttgttatttct 
     M  N  S  L  I  G  L  I  K  I  V  F  F  I  G  I  V  V  I  S   
 
61  gtacatccagctttggctgaaaacaactcagaatgtgtttcatctacaccgaaagactgt 
     V  H  P  A  L  A  E  N  N  S  E  C  V  S  S  T  P  K  D  C   
 
121 ggaccaaataaggtattgaatccgcgcttcttacatcgatgcttttatccacaatgcatc 
     G  P  N  K  V  L  N  P  R  F  L  H  R  C  F  Y  P  Q  C  I 
 
181 acttcgactgaatcgtgtccagatcaacgtcaaatcaaatttaaattgtcgccaagacct 
     T  S  T  E  S  C  P  D  Q  R  Q  I  K  F  K  L  S  P  R  P   
 
241 gaatgcgcatgcagtgatggatttgcttataaatcaattgatacgtgtgcaccgattaat 
     E  C  A  C  S  D  G  F  A  Y  K  S  I  D  T  C  A  P  I  N   
 
301 tcacctgaatgtggacaattgggttacagttggccaccacttccttacacatcatagctt 
     S  P  E  C  G  Q  L  G  Y  S  W  P  P  L  P  Y  T  S  * 
 
361 atttgaattacatttttgcgaatatctccgattataatcgtcaaaattttccgttattga 
 
421 aataaataacccaaaatcc
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Figure 7A: Alignment of two representative proteins from two different groups. The 
conserved cysteine residues between the two proteins are highlighted in grey boxes. 
Alignments between other groups revealed similar conservation patterns (data not 
shown). 
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Identities = 24/100 (24%) 
 
 
11A6 : 1  MDSKMFLLMVAALTVFWITSGIAAPLAEDEPVDRTCTRLNE-----FYAERSSRCDDKYC 60           
          M  K+ ++ VA L        +A+ L  ++     C   NE      Y  + + C D Y  
14A4 :    MSLKLVIIGVALLGF------VASSLGNEDNKPNLCCPQNEKLYDYHYPCKKNMCKDYYD  
 
 
 
11A6 : 61 DGSEIYMKCTQDCSHGYRCRCITGTKRDSHGNCIEENKCN 100           
            S+   K     +    C C  G  R + G C+++  CN 
14A4 :    HSSQNECKLPATFAKNKYCDCKDGYLRTNAGPCVKKEDCN 
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Figure 7B: Multiple alignments of deduced amino acid sequences of M. destructor with 
Ascaris family members, Ascaris trypsin inhibitor (ATI) and Bombina skin trypsin 
inhibitor (BSTI). The P1 reactive site residues are boxed. Towards C-terminal end of P1 
the residues were named as P1’, P2’, P3’….. and towards N-terminal end of P1 the 
residues were named P2, P3, P4…. . Identical residues of all inhibitors are highlighted with 
black background and in clear boxes. Gray shades represent the loosely conserved amino 
acid residues. Conserved cysteine residues are shown in asterisk (*) below the sequence. 
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                                    10                         20                           30                          40                P1      50                                 63 
11A6     ------------------APLAEDEPVDRTCTRLNEFYAERSSRCDDKYCDGS---EIYMKCT 
14A4     --------------------NEDNKPN--LCCPQNEKLYDYHYPCKKNMCKDYYDHSSQNECK 
LG2A3    --------------------EDAQPN---SACPPNETLYDFVDPCRKDTCEKAIKNVGFYECG 
LG2F7    ---------------------CNQDIQSKNCCPENETLYDHDYPCARDTCAKAFDDPAFYECK 
11C4     -----------------NNSECVSSTP-KDCGPNKVLNPRFLHRCFYPQCITS-----TESCP 
ATI      EAEKCTKPNEQWTKCGGCEGTCAQKI------------V----PCTR-------------ECK 
BSTI     -NFVCPPGQTFQTCASSCPKTCETRN--------------KLVLCDK-------------KCN 
                                                     *    *           * 
 
 
 
       70          80           90          100              114 
11A6     ------QDCSHGYRCRCIT--GTKRDSHGNCIEENKCNATKLWL------- 
14A4     LPA----TFAKNKYCDCKD--GYLRTNAGPCVKKEDCNFLIKNEHH----- 
LG2A3    --G----YKTEHPVCNCVD--NFYRNKEGHCVSIDQCRSEING-------- 
LG2F7    FVA----QKSKFRYCNCND--NMFRNKDGYCVSIEQCLLEINGSI------ 
11C4     DQRQIKFKLSPRPECACSDGFAYKSIDTCAPINSPECGQLGYSWPPLPYTS 
ATI      --P---------PRCECIASAGFVRDAQGNCIKFEDCPK------------ 
BSTI     ------------QRCGCISGTVLKSKDSSECVHPSKC-------------- 
                       * *             *     * 
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Figure 7C: Alignment of deduced M. destructor 11A6 protein with a trypsin-inhibitor-
like protein from Caenorhabditis elegans. The conserved cysteine residues between the 
two proteins are highlighted in grey boxes. 
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Identities = 24/69 (34%) 
 
 
11A6 :30  EPVDRTCTRLNEFYAERSSRCDDKYCDGSEIYMKCTQDCSHGYRCRCITGTKRDSHGNCI 89           
          +P++R C R NE +    + C D  C+    +  C Q C+ G  C C  G  RD+ G C+  
TI   :493 KPINRRC–RSNEKFEPCKTVCSDTKCNEEPRF--CPQVCTGG--CVCQEGFFRDNSGKCV 548  
 
 
 
 
11A6 :90  EENKCNATK 98             
           +N C+A K  
TI   :549 TQNDCDAQK 557  
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Figure 8: Total proteins on SDS-PAGE of E. coli (BL21-DE3) containing expression 
constructs 11A6, 14A4, and 8A3. The construct 8A3 expresses an unrelated protein at 
high level in this system as demonstrated before and serve as a positive control in this 
experiment. U - uninduced, I -induced, M - protein standards. Left hand side of gel 
picture shows the size of protein standards. Boxed area shows the induced recombinant 
protein.  
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Figure 9: Purified recombinant proteins 11A6 and 14A4 protein with (+) and 
without (-) N-terminal His-tag. The N-terminal His-tag was removed by using the 
enterokinase enzyme. Left side of figure shows the sizes of the protein standards. 
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Figure 10: Inhibitory activity of recombinant protein 11A6 toward various proteases and 
insect gut extracts. YMW-Yellowmeal worm, RFB-Red flour beetle. Recombinant 
inhibitor was incubated with different proteases at 37oC for 10 minutes before adding 
substrate. The protease activity was measured by monitoring the hydrolysis of casein 
conjugated with BODIPY-TR-X. 
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Figure 11: Stoichiometry of inhibition of trypsin activity. Recombinant 11A6 protein was 
incubated with trypsin at 37oC for 10 minutes at molar ratios ranging from 0:1 to 3.1:1. 
The trypsin activity was measured by monitoring the hydrolysis of casein conjugated to 
BODIPY-TR-X. X-axis shows the molar ratio between inhibitor and trypsin and Y-axis 
shows trypsin activity in percentage. 
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Figure 12: Stoichiometry of inhibition of papain activity. Recombinant 11A6 protein was 
incubated with trypsin at 37oC for 10 minutes at molar ratios ranging from 0:1 to 1.5:1. 
The papain activity was measured by monitoring the hydrolysis of casein conjugated to 
BODIPY-TR-X. X-axis shows the molar ratio between inhibitor and trypsin and Y-axis 
shows trypsin activity in percentage. 
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Figure 13: Inhibitory activity of recombinant protein 14A4 toward various proteases and 
insect gut extracts. YMW-Yellowmeal worm, RFB-Red flour beetle. Recombinant 
inhibitor was incubated with different proteases at 37oC for 10 minutes before adding 
substrate. The protease activity was measured by monitoring the hydrolysis of casein 
conjugated with BODIPY-TR-X. 
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Figure 14: Stoichiometry of inhibition of trypsin activity by 14A4. Recombinant 14A4 
protein was incubated with trypsin at 37oC for 10 minutes at molar ratios ranging from 
0:1 to 4.1:1 before adding substrate. The trypsin activity was measured by monitoring the 
hydrolysis of casein conjugated to BODIPY-TR-X. X-axis shows the inhibitor and 
trypsin molar ration and Y-axis shows trypsin activity in percentage. 
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Figure 15: Stoichiometry of inhibition of chymotrypsin activity. Recombinant 14A4 
protein was incubated with chymotrypsin at 37oC for 10 minutes at molar ratios ranging 
from 0:1 to 4.3:1 before adding substrate. The trypsin activity was measured by 
monitoring the hydrolysis of casein conjugated to BODIPY-TR-X. X-axis shows the 
inhibitor and trypsin molar ration and Y-axis shows trypsin activity in percentage. 
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Figure 16: Northern blot analysis of RNA samples prepared from insects at different 
developmental stages. RNA samples were extracted from 0-day (freshly hatched, 
nonfeeding), 2-day, 4-day, 6-day and 12-day-old larvae, pupae (P), and adults (A), 
respectively, as indicated in the figure. Probes specific to group I (11A6), group II 
(14A4), group III (Lg2A3), group IV (Lg2F7), and group V (11C4) gene groups were 
used for blot analysis. Bottom panel of the figure shows the image of 18s rRNA stained 
with ethidium bromide to show equal loading of RNA. 
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Figure 17A: Regression plot of threshold cycle against the log starting copy number of 
11A6 in the pCR2.1-TOPO plasmid. Correlation coefficient– 0.999 Slope: -3.749 
Intercept: 45.265 , Y = -3.749X + 45.265 
 
 
 
 
 
 
 
 
 
 
 
Figure 17B: Quantitative expression of 11A6 gene in different tissue types. MG-Midgut, 
MT-Malpighian tubule, SG-Salivary gland, FB-Fatbody. 11A6 is abundantly expressed in 
malpighian tubules and similar levels in midgut and salivary glands. Very low levels of 
expression in fatbody and carcass.
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Figure 18A: Regression plot of threshold cycle against the log starting copy number of 
14A4 in the pCR2.1-TOPO plasmid. Correlation coefficient– 0.999 Slope: -3.628 
Intercept: 42.370, Y = -3.628X + 42.370 
 
 
 
 
Figure 18B: Quantitative expression of 14A4 gene in different tissue types. MG-Midgut, 
MT-Malpighian tubule, SG-Salivary gland, FB-Fatbody. 14A4 is abundantly expressed in 
malpighian tubules, similar levels in midgut and salivary glands. Very low levels of 
expression in fatbody and carcass. 
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Figure 19A: Regression plot of threshold cycle against the log starting copy number of 
Lg2A3 in the pCR2.1-TOPO plasmid. Correlation coefficient– 0.999 Slope: -3.626 
Intercept: 49.810, Y = -3.626X + 49.810 
 
 
 
 
 
Figure 19B: Quantitative expression of Lg2A3 gene in different tissues. MG-Midgut, 
MT-Malpighian tubule, SG-Salivary gland, FB-Fatbody. Lg2A3 is abundantly expressed 
in malpighian tubules followed by midgut. Very low levels of expression in salivary 
glands, fatbody and carcass. 
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Figure 20A: Regression plot of threshold cycle against the log starting copy number of 
Lg2F7 in the pCR2.1-TOPO plasmid. Correlation coefficient– 0.999 Slope: -3.821 
Intercept: 47.184, Y = -3.821X + 47.184 
 
 
 
 
 
 
 
 
Figure 20B: Quantitative expression of Lg2F7 gene in different tissues. MG-Midgut, 
MT-Malpighian tubule, SG-Salivary gland, FB-Fatbody. Lg2F7 is abundantly expressed 
in malpighian tubules, similar levels of expression in midgut and salivary glands. Very 
low levels of expression in fatbody and carcass. 
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Figure 21A: Regression plots of threshold cycle against the log starting copy number of 
11C4 in the pCR2.1-TOPO plasmid. Correlation coefficient– 0.998 Slope: -3.628 
Intercept: 42.070, Y = -3.628X + 47.184 
 
 
 
 
 
 
 
 
Figure 21B: Quantitative expression of 11C4 gene in different tissues. MG-Midgut, MT-
Malpighian tubule, SG-Salivary gland, FB-Fatbody. 11C4 is abundantly expressed in 
salivary glands, similar levels of expression in fatbody and malpighian tubules. Low 
levels of expression in midgut and carcass. 
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Figure 22: Immunohistochemical localization of 14A4 inhibitor in the malpighian tubule 
of Mayetiola destructor. Primary antibody of 1:1000 and anti rabbit secondary antibody, 
1:500, conjugated with Cy-3 was used to localize the 14A4 protein. Arrows indicate the 
presence of 14A4. No localization of 14A4 protein in the control.  
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Figure 23: Immunohistochemical localization of 14A4 inhibitor in the midgut of 
Mayetiola destructor. Primary antibody of 1:1000 and anti rabbit secondary antibody, 
1:500, conjugated with Cy-3 was used to localize the 14A4 protein. Arrows indicate the 
presence of 14A4. No localization of 14A4 protein in the control.
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Figure 24: Immunohistochemical localization of 14A4 inhibitor in the salivary glands of 
Mayetiola destructor. Primary antibody of 1:1000 and anti rabbit secondary antibody, 
1:500, conjugated with Cy-3 was used to localize the 14A4 protein. Arrows indicate the 
presence of 14A4. No localization of 14A4 protein in the control. Box A shows both basal 
and tubular region and box B shows the tubular region of salivary gland.
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Figure 25: Western analysis to confirmation antibody specificity and tissue specific 
localization of 14A4 in different tissues of Mayetiola destructor. Primary antibody of 
1:1000 and anti rabbit secondary antibody, 1:1000, was used to identify the presence of 
14A4 protein. HL-Hemolymph, SG-Salivary gland, MGE-Midgut extract, MG-Midgut, 
RP-Recombinant 14A4. 
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Figure 26: Identification of bacterial artificial chromosomes (BAC) clones that contain 
11A6 cDNA related genes. 32P labeled 11A6 cDNA probe was hybridized with BAC 
DNA membrane. Arrows represent the positive BAC clones for 11A6. 
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Figure 27: Identification of bacterial artificial chromosomes (BAC) clones that contain 
14A4 cDNA related genes. 32P labeled 14A4 cDNA probe was hybridized with BAC 
DNA membrane. Arrows represent the positive BAC clones for 14A4.
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Figure 28: Southern blot analysis of BAC DNA using 11A6 cDNA probe. Five µg of 
BAC DNA was digested with different restriction enzymes overnight and the products 
were separated on 1% agarose gel. The agarose separated DNA was transferred on to 
nylon membrane and hybridized with 32P labeled 11A6 cDNA probe. A- EcoRI digest, B-
HindIII digest. Lane 1-8L4 BAC DNA, lane 2-8L18, lane 3-8D19. DNA markers are 
indicated at the left.  
 166
  
 
 
 
 
 
 
 
                A    1        2        3     B     1         2          3 
                          
kb
5 
3 
2 
0.95 
 
    
                 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 167
  
 
 
   
 
 
 
 
 
 
Figure 29: Southern blot analysis of BAC DNA using 14A4 cDNA probe. Five µg of 
BAC DNA was digested with different restriction enzymes overnight and the products 
were separated on 1% agarose gel. The agarose separated DNA was transferred on to 
nylon membrane and hybridized with 32P labeled 14A4 cDNA probe. A-EcoRI digest, B-
HindIII digest. Lane 1-10O2, lane 2-11O4, lane 3-14C5, lane 4-15M14 and lane 5-9013. 
DNA markers are indicated at the left. 
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Table 1: Effect on recombinant Mayetiola destructor inhibitors on BODIPY-TR-X 
casein hydrolysis by serine proteases. 
            
Inhibitor Enzyme Maximum 
Inhibition (%) 
Molar 
Ratio 
IC50 (µM) 
Trypsin 62.11     1.5 : 1 0.52 11A6 
Chymotrypsin - - - 
Trypsin 67.46 3.1 : 1 0.90 14A4 
Chymotrypsin 54.25 3.2 : 1 2.32 
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5. Discussion 
 
5.1 Structural similarity to Ascaris inhibitors 
Fifteen families of serine protease inhibitors have been identified (Reeck et al., 
1997). Each family is characterized by the number of cysteine residues and disulfide 
bonds (Laskowski and Kato, 1980). For example, the pancreatic trypsin inhibitor Kunitz 
family contains 4 to 8 disulfide bonds. The Bowman-Birk inhibitors contain 7 disulfide 
bonds. All of the protease inhibitors I have identified belong to the Ascaris family, which 
have five disulfide bonds (Bernard and Peanasky, 1993).  
All the identified inhibitors contain cysteine residues that are highly conserved. 
The cysteine residues present in these proteins might be involved in forming disulfide 
bonds. Formation of these disulfide bonds could help in optimal folding and maintaining 
three dimensional structures for the inhibitory activity even with a high degree of 
diversification in amino acid sequence. Also they might be involved in holding the two 
chains of the inhibitor by encompassing the reactive site after cleavage by protease 
(Laskowski and Kato, 1980). This is particularly true in Ascaris inhibitors. They entirely 
rely on disulfide bonds for proper folding because they lack a definite hydrophobic 
region (Bernard and Peanasky, 1993; Cierpicki et al., 2000; Zang and Maizels, 2001), and 
at least one disulfide bond encompasses the reactive site (Bernard and Peanasky, 1993). 
Although the identified inhibitors contain cysteine residues, the number of 
cysteine residues varies from 7 to 10. This variation in the number did not affect the 
protease inhibitory activity of recombinant inhibitors 11A6 and 14A4, suggesting that the 
inhibitors can sustain the variation in the number of cysteine residues without altering the 
protein scaffold required for their activity. The Ascaris members, including the insect 
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inhibitors Apis mellifera chymotrypsin/cathepsin-G inhibitor (AMCI-1) and Drosophila 
Acp62F, contain 10 cysteine residues (Bearnard and Peanasky, 1993; Bania et al., 1999; 
Lung et al., 2002).  However, some members like von Willebrand factor contain 11 
cysteines, mouse mucin-6 has 8 cysteines and Anisakis simplex coagulation inhibitor, Ax-
SPI-3 has 9 cysteine residues (Lu et al., 1998; Katsumi et al., 2000; Escande et al., 2004). 
The von Willebrand factor forms 5 intra and 1 inter chain disulfide bonds (Katsumi et al., 
2000). In isolated protease inhibitors, 7 cysteine residues are conserved with Ascaris 
members. Out of these 7 residues the C-terminal 4 cysteine residues are completely 
conserved, suggesting that these residues might be absolutely required for proper folding 
of the protein. In Ascaris family members not only are the 10 cysteine residues conserved 
but the patterns of the disulfide bonds are also completely conserved (Bearnard and 
Peanasky, 1993). 
The isolated protease inhibitors contain a cysteine residue at P2 which is highly 
conserved with the P2 cysteine of Ascaris inhibitors (Bernard and Peanasky, 1993). In 
contrast to this, the cysteine residue present at P2’ position in Ascaris inhibitors is located 
at P3’ position in inhibitors identified from Hessian fly. This change in cysteine position 
is possible if the change does not alter the substrate binding to the enzyme (Bode and 
Huber, 1991; Stanssens et al., 1996). The P2’ located cysteine in Ascaris inhibitors forms 
a disulfide bond, covering the reactive site, with a cysteine located at N-terminal 22nd 
position (Bearnard and Peanasky, 1993). Hence, it is possible that the P3’ located cysteine 
might be involved in forming a disulfide bond encompassing the reactive site in these 
inhibitors. 
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5.2 Diversity in protease inhibitors 
The identified cDNA clones were categorized into five groups based on their 
evolutionary relationship. The five groups of cDNA clones identified possibly code for 
protease inhibitors. Individual members within the same group encode similar proteins 
which could represent different alleles because the cDNA library was made from multiple 
Hessian fly insects. Alternatively, these individual cDNAs could represent different genes 
that arose by gene duplication. Protease inhibitor genes that occur in multiple copies are 
known to have arisen by gene duplication (Ohta, 1994; Prakash et al., 1996; 
Mukhopadhyay, 1999). Indeed, the cDNAs isolated from the Hessian fly salivary glands 
and midguts are usually present in multiple copies which are clustered within a short 
region of the chromosome (Chen et al., 2004). Clustered organization of protease 
inhibitor genes has been reported in plants and animals (Heibges et al., 2003; Puente and 
Lopez-Otin, 2004).  
Individual members within the same group are highly conserved whereas 
members from different groups encode diversified proteins. The sequence identity 
between different members ranged from 25% to 58% (data not shown). The maximum 
overall identity of protease inhibitors with known members of Ascaris inhibitors is 34%. 
Out of this 34% identity, 13% is contributed by the complete conservation of cysteine 
residues whereas the percentage of cysteine content of Ascaris members varies from ~8% 
to ~18% (Babin et al., 1984; Katsumi et al., 2000). Without the cysteine residues the 
overall identity of protease inhibitors with Ascaris members is 21%, which is close to that 
among random sequence alignments. This suggests that the proteins might have 
undergone divergent evolution leading to diversification while maintaining functional 
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integrity. This is particularly the case in Ascaris inhibitors. The Ancylostoma ceylanicum 
anticoagulant protein, AceAp1, is 40-44% identical to two inhibitors, AcApc2 and 
AcAP5, of A. caninum, but all of them have the fundamental protein backbone of Ascaris 
inhibitor family (Harrison et al., 2002). It is believed that divergent evolution of protease 
inhibitors has taken place to counteract the rapidly evolving cognate proteases (Zang and 
Maizels, 2001). Even though they have undergone divergent evolution over a period of 
time, their inhibitory activity is maintained without loosing the cysteine residues at their 
respective positions (Harrison et al., 2002; Zang and Maizels, 2001). 
 
 5.3 Diversity in reactive center region 
The reactive center region residues on either side of P1, except the P2 and P3’ 
cysteine, are highly variable. This variation in the reactive center region leads to variation 
in their specificity towards their target proteases (Laskowski and Kato, 1980; Stanssens et 
al., 1996). This is true because the recombinant proteases exhibit different specificities 
towards commercial proteases. Also the Ascaris family hookworm anticoagulant 
inhibitors, AcAPc2 and AcAP5 exhibit different specificity. Even though both contain a 
P1 arginine, AcAP5 inhibits fXa, a trypsin like enzyme, whereas AcAPc2 does not. This 
is due to the variability of amino acid residues at the reactive center region (Stanssens et 
al., 1996). Similarly with the locust inhibitory peptides, PMP-D2 and HI, both contain an 
arginine specific for trypsin at P1, but they inhibit chymotrypsin (Kellenberger et al., 
2003). The variation in the reactive center region is the common phenomenon found in 
protease inhibitors (Laskowski and Kato, 1980; Hawley and Peanasky, 1992; Gettins, 
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2002) which is due to the occurrence of mutations in the reactive center region that have 
taken place to overcome the evolving target proteases (Nielsen et al., 1998). High 
variation in the amino acid residues at the reactive center region has been observed in 
functionally important domains of various serine protease inhibitors (Babin et al., 1984; 
Hill and Hastie, 1987; Laskowski Jr. et al., 1987; Jiang et al., 1994; Goodwin et al., 
1996). 
In the reactive center region the P1 residue is also highly variable. The group I 
proteins contain a predicted P1 residue aspartic acid which is different from basic and 
aromatic amino acids present in other members. The inhibitors with basic amino acids 
lysine and arginine inhibit trypsin (Laskowski and Kato, 1980). The P1 aspartic acid 
residue is not specific to trypsin inhibition. It is not known how the P1 aspartic acid reacts 
with active site residues of cognate enzyme. Variation in the P1 reactive site is known to 
occur in inhibitors (Laskowski and Kato, 1980).  For example, the pancreatic trypsin 
inhibitor family members contain one of the following residues- arginine, lysine, alanine, 
leucine, aspartic acid, methionine, serine, valine, glutamine, or tyrosine as a P1 residue 
(Laskowski and Kato, 1980). The insect double headed Kazal inhibitor, rhodniin, 
contains aspartic acid as a P1 residue in its second inhibitor domain, Rhod2, whereas the 
first domain, Rhod1, contains histidine as a P1 residue (van de Locht et al., 1995).  
The members in group II except Sg6G2, contain lysine residue at P1 and the 
members in group III and IV contain lysine and arginine, respectively, at P1. The 
members with lysine and arginine inhibit trypsin (Laskowski and Kato, 1980). As 
demonstrated by recombinant protein 14A4, the protein inhibited trypsin activity, 
suggesting that it is a trypsin inhibitor. In addition to inhibiting trypsin it also inhibited 
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chymotrypsin activity. Evaluation of the reactive center region residues revealed that the 
14A4 protein contains a hydrophobic residue proline at P4 position which is not found in 
group I and V proteins. Although the P1 residue confers specificity, it is suggested that 
the residues between P3 and P10 are also responsible in binding interactions of Kunitz 
inhibitors (Kraunsoe et al., 1996; Pritchard and Dufton, 1999; Milestone, 2000). Also, the 
Kunitz type serine protease inhibitor secreted by A. ceylanicum is known to inhibit 
chymotrypsin, trypsin, pancreatic and neutrophil elastase with its P1 residue methionine 
because it contains two extra residues at P3 and P12 (Milestone et al., 2000). It is possible 
that the presence of proline and also other residues in this region might be influencing the 
interaction of 14A4 inhibitor with different proteases.  
In contrast to the presence of lysine at P1 in all other members in group II, Sg6G2 
contains an isoleucine, a hydrophobic amino acid at the P1 site. The isoleucine at P1 site is 
also present in a serpin, MEPI (Gettins, 2002), but it not known how the P1 isoleucine 
interacts with the active site residues of the target enzymes. The chymotrypsin enzyme is 
known to selectively cleave peptide bonds on the carboxyl side of hydrophobic or 
aromatic amino acids (Lu et al., 1997).  
Even though group I (11A6) proteins have an aspartic acid, which can follow 
canonical mechanism of inhibition, the molar ratio suggests otherwise. The stiochiometry 
ratio of inhibitor to trypsin enzyme is greater than 1:1. The anticoagulant inhibitor 
contains two domains, Rhod1 and Rhod2. Rhod1 contains histidine as P1 whereas Rhod2 
contains aspartic acid (van de Locht et al., 1995). The Rhod1 forms a reactive site loop 
which follows the canonical conformation whereas the Rhod2 reactive site loop does not 
follow this conformation even though the rhodniin molecule binds at a 1:1 ratio to the 
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thrombin enzyme. This is because the Rhod2 binding loop contains 3 negatively charged 
residues including P1 aspartic acid and 1 positively charged residue in addition to the 
presence of the 1-amino acid insertion (Friedrich et al., 1993). The Rhod1 binds to the 
active site of the thrombin enzyme but Rhod2 loop binds to the exosite (van de Locht et 
al., 1995). It might be a similar case as that of Rhod2 in 11A6 inhibitor which contains 2 
negatively charged residues at the P1 and P2 site and 1 positively charged residue at the 
P1’ site which can restrict canonical loop formation. Hence 11A6 inhibitor might inhibit 
the proteases noncanonically by binding noncovalently which is also suggested by its 
molar ratio of inhibition. The molar ratio of 14A4 inhibitor is also greater than 1:1 which 
implicates that this inhibitor also inhibits the proteases by binding noncovalently. It could 
be true because binding of inhibitors to proteases did not prevent the hydrolysis of casein 
conjugated fluorescence substrate completely. Bothrojaracin, isolated from the Bothrops 
jararaca, exhibits inhibitory effects by binding to the anion-binding site but does not 
substantially decrease the amidolytic activity of thrombin (Zingali et al., 1993). One 
explanation for not inhibiting the protease activity completely is that binding of inhibitors 
noncovalently to protease might sterically hinder the access of substrate to the active site 
of protease. Another possibility is that binding of inhibitors to protease might change the 
conformation of proteases resulting in lower activity. 
 
5.4 Cross specificity towards different proteases 
The recombinant protease inhibitors exhibited different specificities towards 
different proteases. Protease inhibitor 11A6 inhibited trypsin and also papain at lower 
levels, whereas 14A4 inhibited trypsin and chymotrypsin, suggesting that these 
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recombinant inhibitors posses different specificities. This difference could be due to the 
variation in the reactive center region amino acid residues that impart specificity. The 
hookworm anticoagulant inhibitors have different specificities towards their target 
proteases due to variation in their reactive center region (Stanssens et al., 1996). It is 
possible that the recombinant inhibitors might have domains that could inhibit more than 
one protease. The human LEKT1 has 15 domains and inhibits plasmin, trypsin, elastase, 
subtilisin A and cathepsin G (Mitsudo et al., 2003). Also, the 11A6 and 14A4 
recombinant inhibitors might act more as substrates for chymotrypsin and papain 
proteases, respectively, because no inhibition was observed. It is known that serpin-3 acts 
as more substrate for chymotypsin whereas it inhibits propehnoloxidase, trypsin, elastase 
and plasmin completely (Zhu, 2001). This difference in protease specificities is likely 
caused by conformational effects of peptide bonds in proteases and inhibitor at the 
contact region (Narumi et al., 1993). 
In addition to inhibiting the commercial proteases, the two recombinant proteins 
also inhibited Hessian fly gut protease activity with different levels. The Hessian fly 
midgut contains digestive proteases which are predominantly serine proteases, trypsins 
and chymotrypsins (Zhu et al., 2005). The gut extract proteases that are not specific to 
inhibition by recombinant proteins may use recombinant proteins as substrates at 
different capacities. Hence, this could lead to differences in levels of inhibition by two 
recombinant proteins.  
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Further, both recombinant inhibitors inhibited gut protease activity of yellow 
mealworm and red flour beetle. The inhibition of commercial papain by 11A6 
recombinant inhibitor was less than the inhibition of gut protease activity. No significant 
inhibition of papain by 14A4 recombinant was observed. Both the insect protease extracts 
contain cysteine proteases (Thai and Houseman, 1990; Oppert et al., 2005). Yellowmeal 
worm, in addition to its predominant cysteine proteases activity, also contains serine 
protease activity (Thai and Houseman, 1990). The ability to inhibit cysteine proteases in 
addition to inhibiting serine proteases suggests that the recombinant proteins are cross-
class inhibitors. This cross class inhibition observed by recombinant inhibitors could be 
due to the conformation of the inhibitors that might be well suited to inhibit cysteine 
proteases. Another possibility is that the inhibitors might contain the reactive P1 site 
residue that might be recognized by the cysteine proteases which could lead to their 
inhibition after cleavage. The endopin 2 contains P1 recognition site that are distinct for 
papain and elastase. Hence it inhibits both these enzymes (Hawng et al., 2002). Cross 
class specificity is also observed in a serpin, squamous cell carcinoma antigen 1 (SSCA 
1) that inhibits lysosomal cysteine proteases, cathepsins K, L, and S (Schick et al., 1998) 
and CrmA that inhibits ICE/CED-3-like cysteine proteases (Ray et al., 1992). It is not 
known why the recombinant inhibitors inhibited gut cysteine proteases to a higher extent 
than the commercial enzyme papain, but it is possible that the recombinant inhibitors 
might be more specific to insect cysteine proteases than to commercial papain. 
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5.5 Differential expression pattern of genes 
Except for group V (11C4) all cDNAs are predominantly expressed in the larval 
stage. The expression patterns are quite different. This suggests that cDNAs might have 
different functional targets and specificities towards their cognate enzymes that are 
involved in various biological processes. The cDNAs from group II, III and IV are 
expressed during the initial developmental stages of larva. Possibly these cDNAs have 
roles during early development stages of the larva. In mosquitoes, chymotrypsin 
inhibitors are known to occur at different developmental stages and play a role in the 
developmental process (Horler and Briegel, 1997).  
In contrast to the above four groups of cDNAs, group V was abundantly 
expressed in late larval and pupal stage. It is possible that these cDNAs might be 
regulating proteases present at the pupal stage. Thus they might facilitate pupation and 
may have a role in insect developmental processes. A similar kind of observation is 
described in Drosophila. The Drosophila kil-1 gene is expressed during prepupal stage 
and regulates pupal proteolytic activity (Kress et al., 2004). Expression of kil-1 inhibitor 
in prepupa coincides with decreased protease activity in the molting fluid. Expression of 
serine protease inhibitors in larvae, prepupae and pupae is documented in Aedes, and 
Drosophila (Horler and Briegel, 1997; Kress et al., 2004). 
 
5.6 Tissue specific expression  
All the cDNA groups except group V are abundantly expressed in malpighian 
tubules. This abundant gene expression in malpighian tubules coincides with the 
localization of group II protein 14A4, suggesting that malpighian tubules are the major 
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site of synthesis.  Malpighian tubules are organs that are involved in urine secretion and 
excretion of organic metabolites (Sözen et al., 1997). Hessian fly have three malpighian 
tubules. All three tubules merge at single point and are connected to the midgut at the 
posterior end. The immunolocalized protein in the malpighian tubules is present 
predominantly in the cells located at the tip and middle region of the tubule. Drosophila 
has of two pair (anterior and posterior) of malpighian tubules which consist of two 
tubules. Each tubule pair is divided into six regions: the initial segment present at the tip, 
transition segment, very long middle segment, lower tubule, upper ureter, and lower 
ureter (Sözen et al., 1997). These different segments are composed of different cell types 
and are genetically distinct. The first three regions are composed of principal and stellate 
cells where as the last three regions are composed of very tiny cells. These tiny cells 
secrete neurohormones into the hemolymph that regulate muscle contractility or ion 
transport (Sözen et al., 1997). Our speculation is that the cells located at the tip and 
middle regions of malpighian tubules are involved in synthesizing and secreting 
inhibitors into the hemolymph and to other parts of the insect body to regulate proteolytic 
processes. Indeed, the presence of 14A4 inhibitor was confirmed by the localization in 
the hemolymph (Fig. 25). Hence, these inhibitors may function as extracellular proteins. 
Hessian fly malpighian tubules are freely floating in the hemolymph where 
various serine proteases are present. These protease inhibitors might play a role in 
protecting the malpighian tubules from these destructive proteases by regulating their 
activity inside malpighian cells or near the vicinity. Alternatively, they might be involved 
in regulating the hydrolytic proteases in their own cells but the presence of proteolytic 
enzymes in Hessian fly malpighian tubules has not been demonstrated. The expression of 
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an aminopeptidase gene and the presence of protease activities are documented in the 
malpighian tubules of Trichoplusi ni (Wang et al., 2005).  
In addition to malpighian tubules, expression was observed in the midgut but to a 
lesser extent. The synthesized proteins in the midgut could be secreted into the gut extract 
and hemolymph in addition to their presence in the midgut tissue. Localization of group 
II protein was confirmed in the midgut cells, and further shown by Western analysis that 
these proteins are present in midgut extract and hemolymph. Serine proteases are part of 
the prophenoloxidase cascade system in the insect hemolymph (Ashida, 1990; Soderhall 
and Cerenius, 1998). The inhibitors secreted into the hemolymph could regulate the 
hemolymph proteolytic activity of proteases and thus may have a role in the insect 
defense system. Alternatively, in Hessian fly digestive processes occur in the midgut. The 
midgut contains primarily serine proteases (Zhu et al., 2005).  These inhibitors might be 
involved in protecting midgut cells from destructive protease activity.  
Apart from malpighian tubules and midgut, proteases are also expressed in 
salivary glands. It is possible that synthesized proteins are secreted outside the glands in 
other parts of the insect body to regulate proteases. No protease activity was detected 
when one pair of salivary gland extract was used for the activity assay. Also the salivary 
gland structure is modified in such a way that the tip of the basal region is connected to 
mouth parts and the filament region is free and extends into the hemocele. The protein 
synthesized in the salivary gland could be secreted into the hemolymph. Indeed not much 
of the group II (14A4) protein was detected in the salivary glands (Fig. 25). Also, most of 
the cDNAs isolated from Hessian fly salivary glands and midgut encode secreted proteins 
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(Liu et al., 2004, Chen et al., 2004).  Together midgut and salivary glands may act as 
secondary sites of synthesis of these proteins. 
In contrast to the above four groups of cDNAs, group V cDNAs are abundantly 
expressed in salivary gland followed by fatbody. Northern data shows group V cDNAs 
are expressed in late larval and pupa stages. The proteins synthesized in salivary glands 
probably are secreted outside the salivary glands to regulate the activity of proteases that 
occur during pupal stages (Kress et al., 2004). Hence these proteins might have a role in 
pupa formation. A similar kind of expression pattern of kil-1 gene has been noticed in 
Drosophila. The KIL-1 protein is synthesized in prepupal salivary glands and released 
into the molting fluid during pupation, which coincides with the loss of protease activity 
in pupa (Kress et al., 2004). Group V expression data is similar to that of KIL-1, 
suggesting that inhibitors are involved in developmental processes. The group V cDNAs, 
in addition to their predominant expression in salivary glands, are also expressed in 
fatbody. In Hessian fly, the fat body is present in the hemocele region. The inhibitors 
synthesized in the fat body might be released into insect hemolymph and may participate 
in regulating the proteases of prophenoloxidase cascades. In Manduca, the fatbody 
synthesized serpins play an important role in regulating the serine proteases of 
prophenoloxidase cascades (Zhu, 2001; Tong, 2005). 
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5.7 Gene organization 
Southern analysis of positive BAC clones with group I (11A6) probe identified 
one band, suggesting this is single copy gene in the BAC. Whether this gene is a single 
copy in the whole genome remains to be determined. However, the screening of BAC 
library generated 6 BAC clones. The BAC library constructed contains 6144 clones. If 
the Hessian fly genome is ~160 Mb (personal communication with Dr. Jeff Stuart), then 
1066 BAC clones represent 1 Hessian fly genome. Hence 6144 BAC clones 
approximately represent 6(5.8) Hessian fly genomes. Assuming that the BAC clones 
positive to 11A6 probe were normally represented, then our data is consistent with the 
notion that the group I gene is either a single copy gene or a low copy number gene in the 
genome since as expected 6 BAC clones were identified from the BAC screening that 
represents the ~6 times Hessian fly genome.  
In contrast, multiple bands of group II (14A4) genes ranging from one to five 
were observed in the BACs. This suggests that these genes occur in multiple copies in the 
BAC and hence in the genome. This is true because the nucleotide identity between 
members range from 83% - 95% (data not shown). Also the fact that a few members in 
this group contain additional peptide segments not present in other proteins indicates that 
the group II members represent genes that occur in clusters in the BAC. The serpin genes 
in rats exist in three clusters (Puente and López-Otín et al., 2004). Multiple copies of 
serine protease inhibitor genes have been documented in many other organisms (Potempa 
et al., 1994; Lu et al., 1998; Yan et al., 2001; Heibges et al., 2003). Presence of multiple 
copies of inhibitor genes in the genome is an added advantage because each individual 
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gene can undergo evolution independently and so can counter the evolving target 
proteases in a better way (Zang and Maizels, 2001).  
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6. Conclusions 
 
 
¾ The identified cDNAs code for diversified proteins with highly conserved 
cysteine residues suggesting the maintenance of functional integrity during 
evolution.  
 
¾ The recombinant inhibitors 11A6 and 14A4 inhibited different proteases 
suggesting that the cDNA encoded proteins indeed are protease inhibitors with 
different specificities.  
 
¾ The representative genes are predominantly expressed in first instar stage and 
their expression patterns are highly differential suggesting that inhibitors may 
have different specificities and functional roles. 
 
¾ Group I-IV genes were predominantly expressed in the malpighian tubules 
whereas group V was found in the salivary glands. This implicates that the 
proteins are exclusively synthesized in the malpighian tubules and salivary glands 
respectively.  
 
¾ The group II protein, 14A4, is abundantly localized in the malpighian tubules 
suggesting that the primary route of synthesis and secretion of group protein is 
malpighian tubules and might regulate different functions spatially.  
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¾ The analysis of BACs for group I and group II genes revealed single and multiple 
bands respectively implying that the group I is a single or low copy number gene 
whereas group II is a multi copy gene in the genome.  
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